The impact of for-profit hospital status an the care and outcomes of patients with non-ST-Segment elevation myocardial infarction
Shah, B. R., Glickman, S. W., Liang, L., Gibler, W. B., Ohman, E. M., Pollack, C. V., … Peterson, E. D. (2007). The impact of for-profit hospital status an the care and outcomes of patients with non-ST-Segment elevation myocardial infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 50(15), 1462–68.

Training the Next Generation of Physician-Executives: An Innovative Residency Pathway in Management and Leadership
Ackerly, D. C., Sangvai, D. G., Udayakumar, K., Shah, B. R., Kalman, N. S., Cho, A. H., … Dzau, V. J. (2011). Training the Next Generation of Physician-Executives: An Innovative Residency Pathway in Management and Leadership. ACADEMIC MEDICINE, 86(5), 575–79.

PATIENT PREFERENCES FOR STROKE OUTCOMES
Solomon, N. A., Glick, H. A., Russo, C. J., Lee, J., & Schulman, K. A. (1994). PATIENT PREFERENCES FOR STROKE OUTCOMES. STROKE, 25(9), 1721–25.

Heart failure and a controlled trial investigating outcomes of exercise TraiNing (HF-ACTION): Design and rationale
Whellan, D. J., O'Connor, C. M., Lee, K. L., Keteyian, S. J., Cooper, L. S., Ellis, S. J., … Pina, I. L. (2007). Heart failure and a controlled trial investigating outcomes of exercise TraiNing (HF-ACTION): Design and rationale. AMERICAN HEART JOURNAL, 153(2), 201–11.

Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial
O'Connor, C. M., Whellan, D. J., Lee, K. L., Keteyian, S. J., Cooper, L. S., Ellis, S. J., … Pina, I. L. (2009). Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. NEW ORLEANS,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA: AMER MEDICAL ASSOC.

Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial
Flynn, K. E., Pina, I. L., Whellan, D. J., Lin, L., Blumenthal, J. A., Ellis, S. J., … Weinfurt, K. P. (2009). Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. NEW ORLEANS,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA,LA: AMER MEDICAL ASSOC.

Delivering affordable cancer care in high-income countries
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., … Aapro, M. (2011). Delivering affordable cancer care in high-income countries. LANCET ONCOLOGY, 12(10), 933–80.

Clinical assessment of MR of the brain in nonsurgical inpatients
Hirsch, J. A., Langlotz, C. P., Lee, J., Tanio, C. P., Grossman, R. I., & Schulman, K. A. (1996). Clinical assessment of MR of the brain in nonsurgical inpatients. AMERICAN JOURNAL OF NEURORADIOLOGY, 17(7), 1245–53.

Publication or presentation of results from multicenter clinical trials: Evidence from an academic medical center
Turer, A. T., Mahaffey, K. W., Compton, K. L., Califf, R. M., & Schulman, K. A. (2007). Publication or presentation of results from multicenter clinical trials: Evidence from an academic medical center. AMERICAN HEART JOURNAL, 153(4), 674–80.

Identification of patients with diabetic macular edema from claims data - A validation study
Bearelly, S., Mruthyunjaya, P., Tzeng, J. P., Suner, I. J., Shea, A. M., Lee, J. T., … Lee, P. P. (2008). Identification of patients with diabetic macular edema from claims data - A validation study. ARCHIVES OF OPHTHALMOLOGY, 126(7), 986–89.

Battling the Chargemaster: A Simple Remedy to Balance Billing for Unavoidable Out-of-Network Care
Richman, B. D., Kitzman, N., Milstein, A., & Schulman, K. A. (2017). Battling the Chargemaster: A Simple Remedy to Balance Billing for Unavoidable Out-of-Network Care. AMERICAN JOURNAL OF MANAGED CARE, 23(4), E100-+.

The economics of PCSK-9 inhibitors.
Schulman, K. A., & Reed, S. D. (2017). The economics of PCSK-9 inhibitors. American Heart Journal, 189, 200–201.

The economics of new drugs: can we afford to make progress in a common disease?
Hirsch, B. R., & Schulman, K. A. (2013). The economics of new drugs: can we afford to make progress in a common disease? American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Meeting.

Usability evaluation of a personal health record.
Segall, N., Saville, J. G., L'Engle, P., Carlson, B., Wright, M. C., Schulman, K., & Tcheng, J. E. (2011). Usability evaluation of a personal health record. AMIA ... Annual Symposium Proceedings. AMIA Symposium, 2011, 1233–42.

A Patient Reported Approach to Identify Medical Errors and Improve Patient Safety in the Emergency Department.
Glickman, S. W., Mehrotra, A., Shea, C. M., Mayer, C., Strickler, J., Pabers, S., … Schulman, K. A. (2016). A Patient Reported Approach to Identify Medical Errors and Improve Patient Safety in the Emergency Department. Journal of Patient Safety.

Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation.
Patterson, M. E., Grant, W. C., Glickman, S. W., Massie, B. M., Ammon, S. E., Armstrong, P. W., … Reed, S. D. (2009). Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation. Journal of Cardiac Failure, 15(10), 819–27.

The Evolving Pharmaceutical Benefits Market.
Schulman, K. A., & Richman, B. D. (2018). The Evolving Pharmaceutical Benefits Market. JAMA, 319(22), 2269–70.

Impact of heart failure on patients undergoing major noncardiac surgery
Hammill, B. G., Curtis, L. H., Bennett-Guerrero, E., O'Connor, C. M., Jollis, J. G., Schulman, K. A., & Hernandez, A. F. (2008). Impact of heart failure on patients undergoing major noncardiac surgery. ANESTHESIOLOGY, 108(4), 559–67.

Shifting toward Defined Contributions - Predicting the Effects
Schulman, K. A., Richman, B. D., & Herzlinger, R. E. (2014). Shifting toward Defined Contributions - Predicting the Effects. NEW ENGLAND JOURNAL OF MEDICINE, 370(26), 2462–65.

Health City Cayman Islands and the globalization of health services delivery
Shah, B. R., Narayan, M., Seth, A., & Schulman, K. A. (2014). Health City Cayman Islands and the globalization of health services delivery. AMERICAN HEART JOURNAL, 167(5), 770–74.

Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response
Gellad, Z. F., Muir, A. J., McHutchison, J. G., Sievert, W., Sharara, A. I., Brown, K. A., … Reed, S. D. (2012). Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response. VALUE IN HEALTH, 15(6), 876–86.

A Cautious Path Forward on Accountable Care Organizations
Richman, B. D., & Schulman, K. A. (2011). A Cautious Path Forward on Accountable Care Organizations. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 305(6), 602–3.

Outcomes, health policy, and managed care: Relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure
Flynn, K. E., Lin, L., Ellis, S. J., Russell, S. D., Spertus, J. A., Whellan, D. J., … Weinfurt, K. P. (2009). Outcomes, health policy, and managed care: Relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure. AMERICAN HEART JOURNAL, 158(4), S64–S71.

Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: The HF-ACTION study
Gardin, J. M., Leifer, E. S., Fleg, J. L., Whellan, D., Kokkinos, P., LeBlanc, M.-H., … Kitzman, D. W. (2009). Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: The HF-ACTION study. AMERICAN HEART JOURNAL, 158(4), S45–S52.

N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study
Felker, G. M., Whellan, D., Kraus, W. E., Clare, R., Zannad, F., Donahue, M., … O'Connor, C. M. (2009). N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study. AMERICAN HEART JOURNAL, 158(4), S37–S44.

Baseline differences in the HF-ACTION trial by sex
Pina, I. L., Kokkinos, P., Kao, A., Bittner, V., Saval, M., Clare, B., … Whellan, D. (2009). Baseline differences in the HF-ACTION trial by sex. AMERICAN HEART JOURNAL, 158(4), S16–S23.

External Validity of the Cardiovascular Health Study A Comparison With the Medicare Population
DiMartino, L. D., Hammill, B. G., Curtis, L. H., Gottdiener, J. S., Manolio, T. A., Powe, N. R., & Schulman, K. A. (2009). External Validity of the Cardiovascular Health Study A Comparison With the Medicare Population. MEDICAL CARE, 47(8), 916–23.

Using Medicare Administrative Data to Conduct Postmarketing Surveillance of Follow-On Biologics: Issues and Opportunities
Di Martino, L. D., Curtis, L. H., Williams, R. L., Abernethy, D. R., & Schulman, K. A. (2008). Using Medicare Administrative Data to Conduct Postmarketing Surveillance of Follow-On Biologics: Issues and Opportunities. FOOD AND DRUG LAW JOURNAL, 63(4), 891–900.

PCSK9 Inhibitors and the Choice Between Innovation, Efficiency, and Affordability
Mark, D. B., & Schulman, K. A. (2017). PCSK9 Inhibitors and the Choice Between Innovation, Efficiency, and Affordability. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 318(8), 711–12.

The Impact Of Specialty Pharmaceuticals As Drivers Of Health Care Costs
Hirsch, B. R., Balu, S., & Schulman, K. A. (2014). The Impact Of Specialty Pharmaceuticals As Drivers Of Health Care Costs. HEALTH AFFAIRS, 33(10), 1714–20.

Let's Get SEERious: More Accurate Staging With Consequent High Management Impact Is Not Just Stage Migration Reply
Dinan, M. A., Carpenter, W. R., Patz, E. F., Abernethy, A. P., Biddle, A. K., Schulman, K. A., & Curtis, L. H. (2013). Let's Get SEERious: More Accurate Staging With Consequent High Management Impact Is Not Just Stage Migration Reply. JOURNAL OF CLINICAL ONCOLOGY, 31(6), 820.

Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States
Kamble, S., Schulman, K. A., & Reed, S. D. (2012). Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States. VALUE IN HEALTH, 15(5), 632–38.

Perspective: The Case for Research Justice: Inclusion of Patients With Limited English Proficiency in Clinical Research
Glickman, S. W., Ndubuizu, A., Weinfurt, K. P., Hamilton, C. D., Glickman, L. T., Schulman, K. A., & Cairns, C. B. (2011). Perspective: The Case for Research Justice: Inclusion of Patients With Limited English Proficiency in Clinical Research. ACADEMIC MEDICINE, 86(3), 389–93.

When experiments travel: Clinical trials and the global search for human subjects
Schulman, K. A. (2011). When experiments travel: Clinical trials and the global search for human subjects. JOURNAL OF BIOETHICAL INQUIRY, 8(1), 95–96.

Myocardial perfusion, function, and dyssynchrony in patients with heart failure: Baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial
Atchley, A. E., Kitzman, D. W., Whellan, D. J., Iskandrian, A. E., Ellis, S. J., Pagnanelli, R. A., … Borges-Neto, S. (2009). Myocardial perfusion, function, and dyssynchrony in patients with heart failure: Baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial. AMERICAN HEART JOURNAL, 158(4), S53–S63.

A Health Services Research Agenda for Cellular, Molecular and Genomic Technologies in Cancer Care
Wideroff, L., Phillips, K. A., Randhawa, G., Ambs, A., Armstrong, K., Bennett, C. L., … Scott, J. (2009). A Health Services Research Agenda for Cellular, Molecular and Genomic Technologies in Cancer Care. PUBLIC HEALTH GENOMICS, 12(4), 233–44.

Ethical and Scientific Implications of the Globalization of Clinical Research
Glickman, S. W., McHutchison, J. G., Peterson, E. D., Cairns, C. B., Harrington, R. A., Califf, R. M., & Schulman, K. A. (2009). Ethical and Scientific Implications of the Globalization of Clinical Research. NEW ENGLAND JOURNAL OF MEDICINE, 360(8), 816–23.

Linking inpatient clinical registry data to Medicare claims data using indirect identifiers
Hammill, B. G., Hernandez, A. F., Peterson, E. D., Fonarow, G. C., Schulman, K. A., & Curtis, L. H. (2009). Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. AMERICAN HEART JOURNAL, 157(6), 995–1000.

Physician-Industry Cooperation In The Medical Device Industry
Chatterji, A. K., Fabrizio, K. R., Mitchell, W., & Schulman, K. A. (2008). Physician-Industry Cooperation In The Medical Device Industry. HEALTH AFFAIRS, 27(6), 1532–43.

DECISIONAL CONFLICT AMONG PATIENTS WHO ACCEPT OR DECLINE PARTICIPATION IN PHASE I ONCOLOGY STUDIES
Flynn, K. E., Weinfurt, K. P., Seils, D. M., Lin, L., Burnett, C. B., Schulman, K. A., & Meropol, N. J. (2008). DECISIONAL CONFLICT AMONG PATIENTS WHO ACCEPT OR DECLINE PARTICIPATION IN PHASE I ONCOLOGY STUDIES. JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 3(3), 69–77.

Understanding Frequent Emergency Department Use Among Primary Care Patients
Hardy, M., Cho, A., Stavig, A., Bratcher, M., Dillard, J., Greenblatt, L., & Schulman, K. (2018). Understanding Frequent Emergency Department Use Among Primary Care Patients. POPULATION HEALTH MANAGEMENT, 21(1), 24–31.

A Web-based communication aid for patients with cancer
Meropol, N. J., Egleston, B. L., Buzaglo, J. S., Balshem, A., Benson, A. B., Cegala, D. J., … Weinfurt, K. P. (2013). A Web-based communication aid for patients with cancer. CANCER, 119(7), 1437–45.

Comparative Effectiveness of Nonbiologic versus Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
DeWitt, E. M., Li, Y., Curtis, J. R., Glick, H. A., Greenberg, J. D., Anstrom, K. J., … Reed, S. D. (2013). Comparative Effectiveness of Nonbiologic versus Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis. JOURNAL OF RHEUMATOLOGY, 40(2), 127–36.

Proposed 'Grant-And-Access' Program With Price Caps Could Stimulate Development Of Drugs For Very Rare Diseases
Valverde, A. M., Reed, S. D., & Schulman, K. A. (2012). Proposed 'Grant-And-Access' Program With Price Caps Could Stimulate Development Of Drugs For Very Rare Diseases. HEALTH AFFAIRS, 31(11), 2528–35.

Treatment Patterns for Neovascular Age-Related Macular Degeneration: Analysis of 284 380 Medicare Beneficiaries
Curtis, L. H., Hammill, B. G., Qualls, L. G., Dimartino, L. D., Wang, F., Schulman, K. A., & Cousins, S. W. (2012). Treatment Patterns for Neovascular Age-Related Macular Degeneration: Analysis of 284 380 Medicare Beneficiaries. AMERICAN JOURNAL OF OPHTHALMOLOGY, 153(6), 1116–24.

Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006
Dinan, M. A., Curtis, L. H., Hammill, B. G., Patz, E. F., Abernethy, A. P., Shea, A. M., & Schulman, K. A. (2010). Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 303(16), 1625–31.

Alternative Pay-for-Performance Scoring Methods Implications for Quality Improvement and Patient Outcomes
Glickman, S. W., Boulding, W., Roos, J. M. T., Staelin, R., Peterson, E. D., & Schulman, K. A. (2009). Alternative Pay-for-Performance Scoring Methods Implications for Quality Improvement and Patient Outcomes. MEDICAL CARE, 47(10), 1062–68.

Personalized medicine and disruptive innovation: Implications for technology assessment
Schulman, K. A., Vidal, A. V., & Ackerly, D. C. (2009). Personalized medicine and disruptive innovation: Implications for technology assessment. GENETICS IN MEDICINE, 11(8), 577–81.

Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease
Takahashi, T., Reed, S. D., & Schulman, K. A. (2008). Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease. NEPHROLOGY, 13(5), 419–27.

Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study
Curtis, L. H., Hammill, B. G., Bethel, M. A., Anstrom, K. J., Liao, L., Gottdiener, J. S., & Schulman, K. A. (2008). Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study. CURRENT MEDICAL RESEARCH AND OPINION, 24(1), 41–50.

Organizational Characteristics and Patient Experiences With Hospital Care: A Survey Study of Hospital Chief Patient Experience Officers
Manary, M., Staelin, R., Kosel, K., Schulman, K. A., & Glickman, S. W. (2015). Organizational Characteristics and Patient Experiences With Hospital Care: A Survey Study of Hospital Chief Patient Experience Officers. AMERICAN JOURNAL OF MEDICAL QUALITY, 30(5), 432–40.

An Evaluation of Mobile Health Application Tools
Sama, P. R., Eapen, Z. J., Weinfurt, K. P., Shah, B. R., & Schulman, K. A. (2014). An Evaluation of Mobile Health Application Tools. JMIR MHEALTH AND UHEALTH, 2(2), e19.

Patient-Centered Health Care Delivery Systems: A Framework
Muehlbacher, A. C., Bethge, S., & Schulman, K. A. (2013). Patient-Centered Health Care Delivery Systems: A Framework. INTERNATIONAL JOURNAL OF INTEGRATED CARE, 13.

COSTS OF NEWLY DIAGNOSED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AMONG MEDICARE BENEFICIARIES, 2004-2008
Qualls, L. G., Hammill, B. G., Wang, F., Lad, E. M., Schulman, K. A., Cousins, S. W., & Curtis, L. H. (2013). COSTS OF NEWLY DIAGNOSED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AMONG MEDICARE BENEFICIARIES, 2004-2008. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 33(4), 854–61.

Commentary: Per Capita Payments in Clinical Trials: Reasonable Costs Versus Bounty Hunting
Hall, M. A., Friedman, J. Y., King, N. M. P., Weinfurt, K. P., Schulman, K. A., & Sugarman, J. (2010). Commentary: Per Capita Payments in Clinical Trials: Reasonable Costs Versus Bounty Hunting. ACADEMIC MEDICINE, 85(10), 1554–56.

New York Heart Association functional class predicts exercise parameters in the current era
Russell, S. D., Saval, M. A., Robbins, J. L., Ellestad, M. H., Gottlieb, S. S., Handberg, E. M., … Chandler, B. (2009). New York Heart Association functional class predicts exercise parameters in the current era. AMERICAN HEART JOURNAL, 158(4), S24–S30.

Ownership of Medical Information
Hall, M. A., & Schulman, K. A. (2009). Ownership of Medical Information. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 301(12), 1282–84.

Resource Use and Costs Associated With Diabetic Macular Edema in Elderly Persons
Shea, A. M., Curtis, L. H., Hammill, B. G., Kowalski, J. W., Ravelo, A., Lee, P. P., … Schulman, K. A. (2008). Resource Use and Costs Associated With Diabetic Macular Edema in Elderly Persons. ARCHIVES OF OPHTHALMOLOGY, 126(12), 1748–54.

Prostate-specific antigen screening among young men in the United States
Scales, C. D., Antonelli, J., Curtis, L. H., Schulman, K. A., & Moul, J. W. (2008). Prostate-specific antigen screening among young men in the United States. CANCER, 113(6), 1315–23.

Associations Between Seattle Heart Failure Model Scores and Medical Resource Use and Costs: Findings From HF-ACTION
Li, Y., Levy, W. C., Neilson, M. P., Ellis, S. J., Whellan, D. J., Schulman, K. A., … Reed, S. D. (2014). Associations Between Seattle Heart Failure Model Scores and Medical Resource Use and Costs: Findings From HF-ACTION. JOURNAL OF CARDIAC FAILURE, 20(8), 541–47.

Associations Between Seattle Heart Failure Model Scores and Health Utilities: Findings From HF-ACTION
Li, Y., Neilson, M. P., Whellan, D. J., Schulman, K. A., Levy, W. C., & Reed, S. D. (2013). Associations Between Seattle Heart Failure Model Scores and Health Utilities: Findings From HF-ACTION. JOURNAL OF CARDIAC FAILURE, 19(5), 311–16.

THE POTENTIAL INFLUENCE OF INTERNET-BASED SOCIAL NETWORKING ON THE CONDUCT OF CLINICAL RESEARCH STUDIES
Glickman, S. W., Galhenage, S., McNair, L., Barber, Z., Patel, K., Schulman, K. A., & McHutchison, J. G. (2012). THE POTENTIAL INFLUENCE OF INTERNET-BASED SOCIAL NETWORKING ON THE CONDUCT OF CLINICAL RESEARCH STUDIES. JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 7(1), 71–80.

Can We Close The Income And Wealth Gap Between Specialists And Primary Care Physicians?
Vaughn, B. T., DeVrieze, S. R., Reed, S. D., & Schulman, K. A. (2010). Can We Close The Income And Wealth Gap Between Specialists And Primary Care Physicians? HEALTH AFFAIRS, 29(5), 933–40.

Patient Reactions to Confidentiality, Liability, and Financial Aspects of Informed Consent in Cardiology Research
Fortune-Greeley, A. K., Hardy, N. C., Lin, L., Friedman, J. Y., Lawlor, J. S., Muhlbaier, L. H., … Weinfurt, K. P. (2010). Patient Reactions to Confidentiality, Liability, and Financial Aspects of Informed Consent in Cardiology Research. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 3(2), 151–U90.

Clopidogrel use and clinical events after drug-eluting stent implantation: Findings from the HealthCore Integrated Research Database
Petersen, J. L., Barron, J. J., Hammill, B. G., Cziraky, M. J., Anstrom, K. J., Wahl, P. M., … Curtis, L. H. (2010). Clopidogrel use and clinical events after drug-eluting stent implantation: Findings from the HealthCore Integrated Research Database. AMERICAN HEART JOURNAL, 159(3), 462–U167.

Process of Care Performance Measures and Long-Term Outcomes in Patients Hospitalized With Heart Failure
Patterson, M. E., Hernandez, A. F., Hammill, B. G., Fonarow, G. C., Peterson, E. D., Schulman, K. A., & Curtis, L. H. (2010). Process of Care Performance Measures and Long-Term Outcomes in Patients Hospitalized With Heart Failure. MEDICAL CARE, 48(3), 210–16.

Cost Utility of Sequential Adjuvant Trastuzumab for HER2/Neu-Positive Breast Cancer
Reed, S. D., & Schulman, K. A. (2009). Cost Utility of Sequential Adjuvant Trastuzumab for HER2/Neu-Positive Breast Cancer. VALUE IN HEALTH, 12(5), 637–40.

Considerations of net present value in policy making regarding diagnostic and therapeutic technologies
Califf, R. M., Rasiel, E. B., & Schuhnan, K. A. (2008). Considerations of net present value in policy making regarding diagnostic and therapeutic technologies. AMERICAN HEART JOURNAL, 156(5), 879–85.

Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System
Tseng, P., Kaplan, R. S., Richman, B. D., Shah, M. A., & Schulman, K. A. (2018). Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 319(7), 691–97.

Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure
Reed, S. D., Neilson, M. P., Gardner, M., Li, Y., Briggs, A. H., Polsky, D. E., … Levy, W. C. (2015). Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure. AMERICAN HEART JOURNAL, 170(5), 951–60.

Characteristics of Oncology Clinical Trials Insights From a Systematic Analysis of ClinicalTrials.gov
Hirsch, B. R., Califf, R. M., Cheng, S. K., Tasneem, A., Horton, J., Chiswell, K., … Abernethy, A. P. (2013). Characteristics of Oncology Clinical Trials Insights From a Systematic Analysis of ClinicalTrials.gov. JAMA INTERNAL MEDICINE, 173(11), 972–79.

Variations in Use of PET among Medicare Beneficiaries with Non-Small Cell Lung Cancer, 1998-2007
Dinan, M. A., Curtis, L. H., Carpenter, W. R., Biddle, A. K., Abernethy, A. P., Patz, E. F., … Weinberger, M. (2013). Variations in Use of PET among Medicare Beneficiaries with Non-Small Cell Lung Cancer, 1998-2007. RADIOLOGY, 267(3), 807–17.

Risks of Adverse Events With Therapies for Age-Related Macular Degeneration: A Response
Curtis, L. H., Hammill, B. G., Schulman, K. A., & Cousins, S. W. (2012). Risks of Adverse Events With Therapies for Age-Related Macular Degeneration: A Response. ARCHIVES OF OPHTHALMOLOGY, 130(1), 125–26.

Resource Use and Medical Costs by Cause of Death in HF-ACTION
Li, Y., Whellan, D. J., Dunlap, M. E., Kraus, W. E., Samsa, G., Schulman, K. A., … Reed, S. D. (2011). Resource Use and Medical Costs by Cause of Death in HF-ACTION. JOURNAL OF CARDIAC FAILURE, 17(8), S78.

Use of Patient-Reported Outcomes in Randomized, Double-Blind, Placebo-Controlled Clinical Trials
Dinan, M. A., Compton, K. L., Dhillon, J. K., Hammill, B. G., DeWitt, E. M., Weinfurt, K. P., & Schulman, K. A. (2011). Use of Patient-Reported Outcomes in Randomized, Double-Blind, Placebo-Controlled Clinical Trials. MEDICAL CARE, 49(4), 415–19.

Increased rate of central venous catheterization procedures in community EDs
Glickman, S. W., Krubert, C., Koppenhaver, J., Glickman, L. T., Schulman, K. A., & Cairns, C. B. (2010). Increased rate of central venous catheterization procedures in community EDs. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 28(2), 208–12.

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
Flockhart, D. A., O'Kane, D., Williams, M. S., Watson, M. S., Flockhart, D. A., Gage, B., … Watson, M. S. (2008). Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. GENETICS IN MEDICINE, 10(2), 139–50.

Extreme Home Makeover - The Role of Intensive Home Health Care
Ticona, L., & Schulman, K. A. (2016). Extreme Home Makeover - The Role of Intensive Home Health Care. NEW ENGLAND JOURNAL OF MEDICINE, 375(18), 1707–9.

Exploring Variation in Care: Alternative Conceptual Models
Dinan, M. A., & Schulman, K. A. (2014). Exploring Variation in Care: Alternative Conceptual Models. ANNALS OF INTERNAL MEDICINE, 161(11), 835–U130.

Associations Between Hemoglobin Level, Resource Use, and Medical Costs in Patients With Heart Failure: Findings From HF-ACTION
Reed, S. D., Li, Y., Ellis, S. J., Isitt, J. J., Cheng, S., Schulman, K. A., & Whellan, D. J. (2012). Associations Between Hemoglobin Level, Resource Use, and Medical Costs in Patients With Heart Failure: Findings From HF-ACTION. JOURNAL OF CARDIAC FAILURE, 18(10), 784–91.

Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure
Hernandez, A. F., Fonarow, G. C., Hammill, B. G., Al-Khatib, S. M., Yancy, C. W., O'Connor, C. M., … Curtis, L. H. (2010). Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure. CIRCULATION-HEART FAILURE, 3(1), 7–13.

Disclosure of Financial Relationships to Participants in Clinical Research.
Weinfurt, K. P., Hall, M. A., King, N. M. P., Friedman, J. Y., Schulman, K. A., & Sugarman, J. (2009). Disclosure of Financial Relationships to Participants in Clinical Research. NEW ENGLAND JOURNAL OF MEDICINE, 361(9), 916–21.

Fueling Innovation In Medical Devices (And Beyond): Venture Capital In Health Care
Ackerly, D. C., Valverde, A. M., Diener, L. W., Dossary, K. L., & Schulman, K. A. (2009). Fueling Innovation In Medical Devices (And Beyond): Venture Capital In Health Care. HEALTH AFFAIRS, 28(1), W68–W75.

Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005
Curtis, L. H., Greiner, M. A., Hammill, B. G., Kramer, J. M., Whellan, D. J., Schulman, K. A., & Hernandez, A. F. (2008). Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005. ARCHIVES OF INTERNAL MEDICINE, 168(22), 2481–88.

Medical costs of abnormal serum sodium levels
Shea, A. M., Hammill, B. G., Curtis, L. H., Szczech, L. A., & Schulman, K. A. (2008). Medical costs of abnormal serum sodium levels. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(4), 764–70.

Does the market value racial and ethnic concordance in physician-patient relationships?
Brown, T. T., Scheffler, R. M., Tom, S. E., & Schulman, K. A. (2007). Does the market value racial and ethnic concordance in physician-patient relationships? HEALTH SERVICES RESEARCH, 42(2), 706–26.

Trends in Hospital-Physician Integration in Medical Oncology
Clough, J. D., Dinan, M. A., & Schulman, K. A. (2017). Trends in Hospital-Physician Integration in Medical Oncology. AMERICAN JOURNAL OF MANAGED CARE, 23(10), 624–27.

Reassessing ACOs and Health Care Reform
Schulman, K. A., & Richman, B. D. (2016). Reassessing ACOs and Health Care Reform. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 316(7), 707–8.

Implications of Definitions of Simultaneous and Staged Bilateral Total Knee Replacement (TKR) in Device Epidemiology for Medicare Beneficiaries
Setoguchi, S., Greiner, M. A., Pietrobon, R., Attarian, D., Kelley, S., Wellman, S., … Bolognesi, M. (2011). Implications of Definitions of Simultaneous and Staged Bilateral Total Knee Replacement (TKR) in Device Epidemiology for Medicare Beneficiaries. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 20, S234–S235.

Seattle Heart Failure Model Scores Significantly Predict Medical Resource Use and Costs in HF-ACTION
Reed, S. D., Li, Y., Ellis, S. J., Whellan, D. J., Schulman, K. A., O'Connor, C. M., & Levy, W. C. (2011). Seattle Heart Failure Model Scores Significantly Predict Medical Resource Use and Costs in HF-ACTION. JOURNAL OF CARDIAC FAILURE, 17(8), S80.

Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States
Shea, A. M., Curtis, L. H., Szczech, L. A., & Schulman, K. A. (2008). Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States. BMC NEPHROLOGY, 9, 5.

Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries
Hernandez, A. F., Shea, A. M., Milano, C. A., Rogers, J. G., Hammill, B. G., O'Connor, C. M., … Curtis, L. H. (2008). Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 300(20), 2398–2406.

Use Of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs
Reed, S. D., Anstrom, K. J., Seils, D. M., Califf, R. M., & Schulman, K. A. (2008). Use Of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs. HEALTH AFFAIRS, 27(5), W360–W370.

Outcomes of second revascularization procedures after stent implantation
Konstance, R. P., Eisenstein, E. L., Anstrom, K. J., Shaw, L. K., Califf, R. M., Harrington, R. A., … Kong, D. F. (2008). Outcomes of second revascularization procedures after stent implantation. JOURNAL OF MEDICAL SYSTEMS, 32(2), 177–86.

Incidence and prevalence of heart failure in elderly persons, 1994-2003
Curtis, L. H., Whellan, D. J., Hammill, B. G., Hernandez, A. F., Anstrom, K. J., Shea, A. M., & Schulman, K. A. (2008). Incidence and prevalence of heart failure in elderly persons, 1994-2003. ARCHIVES OF INTERNAL MEDICINE, 168(4), 418–24.

Market-Based Solutions to Antitrust Threats - The Rejection of the Partners Settlement
Herzlinger, R. E., Richman, B. D., & Schulman, K. A. (2015). Market-Based Solutions to Antitrust Threats - The Rejection of the Partners Settlement. NEW ENGLAND JOURNAL OF MEDICINE, 372(14), 1287–89.

Improving the impact of clinical research: A systematic analysis of kidney cancer trials.
Hirsch, B. R., Mitchell, A., Cheng, S. K., Tasneem, A., Schulman, K. A., Dilts, D. M., & Abernethy, A. P. (2012). Improving the impact of clinical research: A systematic analysis of kidney cancer trials. JOURNAL OF CLINICAL ONCOLOGY, 30(15).

Geographic Variation in Carotid Revascularization Among Medicare Beneficiaries, 2003-2006
Patel, M. R., Greiner, M. A., DiMartino, L. D., Schulman, K. A., Duncan, P. W., Matchar, D. B., & Curtis, L. H. (2010). Geographic Variation in Carotid Revascularization Among Medicare Beneficiaries, 2003-2006. ARCHIVES OF INTERNAL MEDICINE, 170(14), 1218–25.

Specialty Pharmaceuticals for Hyperlipidemia - Impact on Insurance Premiums
Schulman, K. A., Balu, S., & Reed, S. D. (2015). Specialty Pharmaceuticals for Hyperlipidemia - Impact on Insurance Premiums. NEW ENGLAND JOURNAL OF MEDICINE, 373(17), 1591–93.

Predicting Nursing Home Placement Among Home- and Community-Based Services Program Participants
Greiner, M. A., Qualls, L. G., Iwata, I., White, H. K., Molony, S. L., Sullivan, M. T., … Setoguchi, S. (2014). Predicting Nursing Home Placement Among Home- and Community-Based Services Program Participants. AMERICAN JOURNAL OF MANAGED CARE, 20(12), E535-+.

Removing a Constraint on Hospital Utilization: A Natural Experiment in Maryland
Kalman, N. S., Hammill, B. G., Murray, R. B., & Schulman, K. A. (2014). Removing a Constraint on Hospital Utilization: A Natural Experiment in Maryland. AMERICAN JOURNAL OF MANAGED CARE, 20(6), E191–E199.

A model for the adoption of ICT by health workers in Africa
Jimoh, L., Pate, M. A., Lin, L., & Schulman, K. A. (2012). A model for the adoption of ICT by health workers in Africa. INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 81(11), 773–81.

Patient Satisfaction and Its Relationship With Clinical Quality and Inpatient Mortality in Acute Myocardial Infarction
Glickman, S. W., Boulding, W., Manary, M., Staelin, R., Roe, M. T., Wolosin, R. J., … Schulman, K. A. (2010). Patient Satisfaction and Its Relationship With Clinical Quality and Inpatient Mortality in Acute Myocardial Infarction. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 3(2), 188–95.

Clinical Effectiveness of Beta-Blockers in Heart Failure Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry
Hernandez, A. F., Hammill, B. G., O'Connor, C. M., Schulman, K. A., Curtis, L. H., & Fonarow, G. C. (2009). Clinical Effectiveness of Beta-Blockers in Heart Failure Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 53(2), 184–92.

Health Care Tax Inversions - Robbing Both Peter and Paul
Warraich, H. J., & Schulman, K. A. (2016). Health Care Tax Inversions - Robbing Both Peter and Paul. NEW ENGLAND JOURNAL OF MEDICINE, 374(11), 1005–7.

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure
Dardas, T., Li, Y., Reed, S. D., O'Connor, C. M., Whellan, D. J., Ellis, S. J., … Levy, W. C. (2015). Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 34(8), 1017–23.

Financial Incentives in Primary Care Practice The Struggle to Achieve Population Health Goals
Dolor, R. J., & Schulman, K. A. (2013). Financial Incentives in Primary Care Practice The Struggle to Achieve Population Health Goals. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 310(10), 1031–32.

Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function: Analysis of Data Collected Alongside a 48-Week Multicenter Clinical Trial
DeWitt, E. M., Grussemeyer, C. A., Friedman, J. Y., Dinan, M. A., Lin, L., Schulman, K. A., & Reed, S. D. (2012). Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function: Analysis of Data Collected Alongside a 48-Week Multicenter Clinical Trial. VALUE IN HEALTH, 15(2), 277–83.

Changes in Initial Treatment for Prostate Cancer Among Medicare Beneficiaries, 1999-2007
Dinan, M. A., Robinson, T. J., Zagar, T. M., Scales, C. D., Curtis, L. H., Reed, S. D., … Schulman, K. A. (2012). Changes in Initial Treatment for Prostate Cancer Among Medicare Beneficiaries, 1999-2007. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(5), E781–E786.

Ethical and Scientific Implications of the Globalization of Clinical Research REPLY
Glickman, S. W., Cairns, C. B., & Schulman, K. A. (2009). Ethical and Scientific Implications of the Globalization of Clinical Research REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 360(26), 2793.

Characteristics of hospitalizations of HIV-infected patients: An analysis of data from the 1994 Healthcare Cost and Utilization Project
Bentham, W. D., Cai, L. M., & Schulman, K. A. (1999). Characteristics of hospitalizations of HIV-infected patients: An analysis of data from the 1994 Healthcare Cost and Utilization Project. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 22(5), 503–8.

Challenges in enrollment of minority, pediatric, and geriatric patients in emergency and acute care clinical research
Glickman, S. W., Anstrom, K. J., Lin, L., Chandra, A., Laskowitz, D. T., Woods, C. W., … Cairns, C. B. (2008). Challenges in enrollment of minority, pediatric, and geriatric patients in emergency and acute care clinical research. ANNALS OF EMERGENCY MEDICINE, 51(6), 775–80.

Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia
Reed, S. D., Anstrom, K. J., Li, Y., & Schulman, K. A. (2008). Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia. PHARMACOECONOMICS, 26(5), 435–46.

Review: In adult outpatients, nurse-managed protocols improve hemoglobin A(1c) levels and blood pressure Commentary
Schulman, K. A. (2014). Review: In adult outpatients, nurse-managed protocols improve hemoglobin A(1c) levels and blood pressure Commentary. ANNALS OF INTERNAL MEDICINE, 161(12), JC6.

Urinary Diversion in Patients With Spinal Cord Injury in the United States
Peterson, A. C., Curtis, L. H., Shea, A. M., Borawski, K. M., Schulman, K. A., & Scales, C. D. (2012). Urinary Diversion in Patients With Spinal Cord Injury in the United States. UROLOGY, 80(6), 1247–51.

Bladder Augmentation Versus Urinary Diversion in Patients With Spina Bifida in the United States
Wiener, J. S., Antonelli, J., Shea, A. M., Curtis, L. H., Schulman, K. A., Krupski, T. L., & Scales, C. D. (2011). Bladder Augmentation Versus Urinary Diversion in Patients With Spina Bifida in the United States. JOURNAL OF UROLOGY, 186(1), 161–65.

Resource use and costs of branch and central retinal vein occlusion in the elderly
Fekrat, S., Shea, A. M., Hammill, B. G., Nguyen, H., Kowalski, J. W., Schulman, K. A., & Curtis, L. H. (2010). Resource use and costs of branch and central retinal vein occlusion in the elderly. CURRENT MEDICAL RESEARCH AND OPINION, 26(1), 223–30.

Using health communication best practices to develop a web-based provider-patient communication aid: The CONNECT (TM) study
Fleisher, L., Buzaglo, J., Collins, M., Millard, J., Miller, S. M., Egleston, B. L., … Meropol, N. J. (2008). Using health communication best practices to develop a web-based provider-patient communication aid: The CONNECT (TM) study. PATIENT EDUCATION AND COUNSELING, 71(3), 378–87.

Underuse of left ventricular function assessment in patients with newly diagnosed heart failure
Curtis, L. H., Shea, A. M., Hammill, B. G., Schulman, K. A., & Douglas, P. S. (2008). Underuse of left ventricular function assessment in patients with newly diagnosed heart failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 51(10), A238–A239.

Geographic and network analysis of oncology trials: Portfolio assessment of ClinicalTrials.gov.
Cheng, S. K., Hirsch, B. R., Califf, R. M., Tasneem, A., Schulman, K. A., Abernethy, A. P., & Dilts, D. M. (2012). Geographic and network analysis of oncology trials: Portfolio assessment of ClinicalTrials.gov. JOURNAL OF CLINICAL ONCOLOGY, 30(15).

Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
Curtis, L. H., Hammill, B. G., Schulman, K. A., & Cousins, S. W. (2010). Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration. ARCHIVES OF OPHTHALMOLOGY, 128(10), 1273–79.

STAR 3 Randomized Controlled Trial to Compare Sensor-Augmented Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 1 Diabetes: Research Design, Methods, and Baseline Characteristics of Enrolled Subjects
Davis, S. N., Horton, E. S., Battelino, T., Rubin, R. R., Schulman, K. A., & Tamborlane, W. V. (2010). STAR 3 Randomized Controlled Trial to Compare Sensor-Augmented Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 1 Diabetes: Research Design, Methods, and Baseline Characteristics of Enrolled Subjects. DIABETES TECHNOLOGY & THERAPEUTICS, 12(4), 249–55.

Clopidogrel Use and Clinical Events After Drug-Eluting Stent Implantation: Findings From the HealthCore Integrated Research Database
Petersen, J. L., Barron, J. D., Hammill, B. G., Cziraky, M. J., Anstrom, K. J., Wahl, P. M., … Curtis, L. H. (2009). Clopidogrel Use and Clinical Events After Drug-Eluting Stent Implantation: Findings From the HealthCore Integrated Research Database. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 53(10), A11–A12.

Can Team-Based Care Improve Patient Satisfaction? A Systematic Review of Randomized Controlled Trials
Wen, J., & Schulman, K. A. (2014). Can Team-Based Care Improve Patient Satisfaction? A Systematic Review of Randomized Controlled Trials. PLOS ONE, 9(7), e100603.

Our failure to advance new treatments for glioma to market
Sampson, J. H., Kaminski, T. J., & Schulman, K. A. (2011). Our failure to advance new treatments for glioma to market. JOURNAL OF NEUROSURGERY, 115(2), 245–47.

Effects of Family History and Genetic Polymorphism on the Cost-Effectiveness of Chemoprevention With Finasteride for Prostate Cancer
Reed, S. D., Scales, C. D., Stewart, S. B., Sun, J., Moul, J. W., Schulman, K. A., & Xu, J. (2011). Effects of Family History and Genetic Polymorphism on the Cost-Effectiveness of Chemoprevention With Finasteride for Prostate Cancer. JOURNAL OF UROLOGY, 185(3), 841–47.

Relationships between emerging measures of heart failure processes of care and clinical outcomes
Hernandez, A. F., Hammill, B. G., Peterson, E. D., Yancy, C. W., Schulman, K. A., Curtis, L. H., & Fonarow, G. C. (2010). Relationships between emerging measures of heart failure processes of care and clinical outcomes. AMERICAN HEART JOURNAL, 159(3), 406–13.

Understanding heart failure through the HF-ACTION baseline characteristics
O'Connor, C. M., & Whellan, D. J. (2009). Understanding heart failure through the HF-ACTION baseline characteristics. AMERICAN HEART JOURNAL, 158(4), S1–S5.

Modeling the Potential Economic Impact of the Medicare Comprehensive Care for Joint Replacement Episode-Based Payment Model
Maniya, O. Z., Mather, R. C., Attarian, D. E., Mistry, B., Chopra, A., Strickland, M., & Schulman, K. A. (2017). Modeling the Potential Economic Impact of the Medicare Comprehensive Care for Joint Replacement Episode-Based Payment Model. JOURNAL OF ARTHROPLASTY, 32(11), 3268-+.

Financing and Distribution of Pharmaceuticals in the United States
Dabora, M. C., Turaga, N., & Schulman, K. A. (2017). Financing and Distribution of Pharmaceuticals in the United States. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 318(1), 21–22.

Seattle Heart Failure Model Scores are Significantly Predictive of Health Utilities and Their Change Over Time
Li, Y., Neilson, M., Whellan, D. J., Schulman, K. A., Levy, W. C., & Reed, S. D. (2012). Seattle Heart Failure Model Scores are Significantly Predictive of Health Utilities and Their Change Over Time. JOURNAL OF CARDIAC FAILURE, 18(8), S81.

Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs
Ackerly, D. C., Glickman, S. W., & Schulman, K. A. (2010). Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs. PHARMACOECONOMICS, 28(5), 429–38.

Using item banks to construct measures of patient reported outcomes in clinical trials: investigator perceptions
Flynn, K. E., Dombeck, C. B., DeWitt, E. M., Schulman, K. A., & Weinfurt, K. P. (2008). Using item banks to construct measures of patient reported outcomes in clinical trials: investigator perceptions. CLINICAL TRIALS, 5(6), 575–86.

Barriers to Achieving Economies of Scale in Analysis of EHR Data A Cautionary Tale
Sendak, M. P., Balu, S., & Schulman, K. A. (2017). Barriers to Achieving Economies of Scale in Analysis of EHR Data A Cautionary Tale. APPLIED CLINICAL INFORMATICS, 8(3), 826–31.

Economic Evaluation of Pharmaceuticals and Clinical Practice
Schulman, K. A., Glick, H. A., Polsky, D., & John, K. R. (2008). Economic Evaluation of Pharmaceuticals and Clinical Practice. DRUG BENEFITS AND RISKS: INTERNATIONAL TEXTBOOK OF CLINICAL PHARMACOLOGY, 37–55.

Costs of Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage
Chou, C.-H., Reed, S. D., Allsbrook, J. S., Steele, J. L., Schulman, K. A., & Alexander, M. J. (2010). Costs of Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. NEUROSURGERY, 67(2), 345–51.

Oversight of Financial Conflicts of Interest in Commercially Sponsored Research in Academic and Nonacademic Settings
Weinfurt, K. P., Hall, M. A., Hardy, N. C., Friedman, J. Y., Schulman, K. A., & Sugarman, J. (2010). Oversight of Financial Conflicts of Interest in Commercially Sponsored Research in Academic and Nonacademic Settings. JOURNAL OF GENERAL INTERNAL MEDICINE, 25(5), 460–64.

Outcomes of Staphylococcus aureus Infection in Hemodialysis-Dependent Patients
Li, Y., Friedman, J. Y., O'Neal, B. F., Hohenboken, M. J., Griffiths, R. I., Stryjewski, M. E., … Reed, S. D. (2009). Outcomes of Staphylococcus aureus Infection in Hemodialysis-Dependent Patients. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 4(2), 428–34.

Does reimportation reduce price differences for prescription drugs? Lessons from the European Union
Kyle, M. K., Allsbrook, J. S., & Schulman, K. A. (2008). Does reimportation reduce price differences for prescription drugs? Lessons from the European Union. HEALTH SERVICES RESEARCH, 43(4), 1308–24.

Medical Resource Use, Costs, and Quality of Life in Patients With Acute Decompensated Heart Failure: Findings From ASCEND-HF
Reed, S. D., Kaul, P., Li, Y., Eapen, Z. J., Davidson-Ray, L., Schulman, K. A., … Califf, R. M. (2013). Medical Resource Use, Costs, and Quality of Life in Patients With Acute Decompensated Heart Failure: Findings From ASCEND-HF. JOURNAL OF CARDIAC FAILURE, 19(9), 611–20.

Stage Migration, Selection Bias, and Survival Associated With the Adoption of Positron Emission Tomography Among Medicare Beneficiaries With Non-Small-Cell Lung Cancer, 1998-2003
Dinan, M. A., Curtis, L. H., Carpenter, W. R., Biddle, A. K., Abernethy, A. P., Patz, E. F., … Weinberger, M. (2012). Stage Migration, Selection Bias, and Survival Associated With the Adoption of Positron Emission Tomography Among Medicare Beneficiaries With Non-Small-Cell Lung Cancer, 1998-2003. JOURNAL OF CLINICAL ONCOLOGY, 30(22), 2725–30.

Factors influencing the participation of gastroenterologists and hepatologists in clinical research
Dev, A. T., Kauf, T. L., Zekry, A., Patel, K., Heller, K., Schulman, K. A., & McHutchison, J. G. (2008). Factors influencing the participation of gastroenterologists and hepatologists in clinical research. BMC HEALTH SERVICES RESEARCH, 8, 1–11.

Response to Letter Regarding Article, "Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial"
Massie, B. M., Ammon, S. E., Collins, J. F., Krol, W. F., Armstrong, P. W., Cleland, J. G. F., … Warren, S. (2009). Response to Letter Regarding Article, "Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial". CIRCULATION, 120(20), E165.

A policy approach to the development of molecular diagnostic tests
Schulman, K. A., & Tunis, S. R. (2010). A policy approach to the development of molecular diagnostic tests. NATURE BIOTECHNOLOGY, 28(11), 1157–59.

Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures
Dinan, M. A., Chou, C.-H., Hammill, B. G., Graham, F. L., Schulman, K. A., Telen, M. J., & Reed, S. D. (2009). Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures. AMERICAN JOURNAL OF HEMATOLOGY, 84(11), 703–9.

Cost Effectiveness of Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
Reed, S. D., Li, Y., Anstrom, K. J., & Schulman, K. A. (2009). Cost Effectiveness of Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment. JOURNAL OF CLINICAL ONCOLOGY, 27(13), 2185–91.

Patient and Implanting Physician Factors Associated With Mortality and Complications After Implantable Cardioverter-Defibrillator Implantation, 2002-2005
Al-Khatib, S. M., Greiner, M. A., Peterson, E. D., Hernandez, A. F., Schulman, K. A., & Curtis, L. H. (2008). Patient and Implanting Physician Factors Associated With Mortality and Complications After Implantable Cardioverter-Defibrillator Implantation, 2002-2005. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 1(4), 240–49.

Cost of Inpatient Care for Medicare Heart Failure Patients, 2001-2004:More Than Just Heart Failure
Whellan, D. J., Greiner, M. A., Schulman, K. A., & Curtis, L. H. (2008). Cost of Inpatient Care for Medicare Heart Failure Patients, 2001-2004:More Than Just Heart Failure. CIRCULATION, 118(18), S713.

Primary PCI in ST-segment elevation myocardial infarction
Glickman, S. W., Schulman, K. A., & Cairns, C. B. (2008). Primary PCI in ST-segment elevation myocardial infarction. NEW ENGLAND JOURNAL OF MEDICINE, 358(16), 1751–52.

Economic implications of potential changes to regulatory and reimbursement policies for medical devices
Reed, S. D., Shea, A. M., & Schulman, K. A. (2008). Economic implications of potential changes to regulatory and reimbursement policies for medical devices. JOURNAL OF GENERAL INTERNAL MEDICINE, 23, 50–56.

Patient Preferences for Features of Health Care Delivery Systems: A Discrete Choice Experiment
Muehlbacher, A. C., Bethge, S., Reed, S. D., & Schulman, K. A. (2016). Patient Preferences for Features of Health Care Delivery Systems: A Discrete Choice Experiment. HEALTH SERVICES RESEARCH, 51(2), 704–27.

Options to Promote Competitive Generics Markets in the United States
Wiske, C. P., Ogbechie, O. A., & Schulman, K. A. (2015). Options to Promote Competitive Generics Markets in the United States. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(20), 2129–30.

Effect of Cardiac Rehabilitation Visits on Mortality among Elderly Medicare Beneficiaries with Heart Failure
Whellan, D. J., Hammill, B. G., Schulman, K. A., & Curtis, L. H. (2009). Effect of Cardiac Rehabilitation Visits on Mortality among Elderly Medicare Beneficiaries with Heart Failure. JOURNAL OF CARDIAC FAILURE, 15(6), S99.

Association between the medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy
Shea, A. M., Curtis, L. H., Hammill, B. G., DiMartino, L. D., Abernethy, A. P., & Schulman, K. A. (2008). Association between the medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 300(2), 189–96.

The relationship between care patterns and receipt of ICDs among medicare beneficiaries
Curtis, L. H., Greiner, M. A., Hernandez, A. F., & Schulman, K. A. (2008). The relationship between care patterns and receipt of ICDs among medicare beneficiaries. CIRCULATION, 117(21), E429.

Patient Time Costs Associated with Sensor-Augmented Insulin Pump Therapy for Type 1 Diabetes: Results from the STAR 3 Randomized Trial
Kamble, S., Weinfurt, K. P., Schulman, K. A., & Reed, S. D. (2013). Patient Time Costs Associated with Sensor-Augmented Insulin Pump Therapy for Type 1 Diabetes: Results from the STAR 3 Randomized Trial. MEDICAL DECISION MAKING, 33(2), 215–24.

Systemic and Ocular Risks Associated With Therapies for Macular Degeneration: Clarification vs Confusion reply
Curtis, L. H., Hammill, B. G., Schulman, K. A., & Cousins, S. W. (2012). Systemic and Ocular Risks Associated With Therapies for Macular Degeneration: Clarification vs Confusion reply. ARCHIVES OF OPHTHALMOLOGY, 130(6), 807.

Effects of disclosing financial interests on participation in medical research: A randomized vignette trial
Weinfurt, K. P., Hall, M. A., Friedman, J. Y., Hardy, N. C., Fortune-Greeley, A. K., Lawlor, J. S., … Sugarman, J. (2008). Effects of disclosing financial interests on participation in medical research: A randomized vignette trial. AMERICAN HEART JOURNAL, 156(4), 689–97.

Effect of cardiac rehabilitation visits on survival among medicare beneficiaries
Hammill, B. G., Curtis, L. H., Schulman, K. A., & Whellan, D. (2008). Effect of cardiac rehabilitation visits on survival among medicare beneficiaries. CIRCULATION, 117(21), E417.

Economic Evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) Randomized Controlled Trial An Exercise Training Study of Patients With Chronic Heart Failure
Reed, S. D., Whellan, D. J., Li, Y., Friedman, J. Y., Ellis, S. J., Pina, I. L., … Schulman, K. A. (2010). Economic Evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) Randomized Controlled Trial An Exercise Training Study of Patients With Chronic Heart Failure. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 3(4), 374–81.

Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction
Keteyian, S. J., Isaac, D., Thadani, U., Roy, B. A., Bensimhon, D. R., McKelvie, R., … Kraus, W. E. (2009). Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. AMERICAN HEART JOURNAL, 158(4), S72–S77.

Cost of Exercise Training and Its Impact on Medical Resource Use and Costs: Results of HF-ACTION
Reed, S. D., Whellan, D. J., Li, Y., Friedman, J. Y., Pina, I. L., Settles, S. J., … Schulman, K. A. (2009). Cost of Exercise Training and Its Impact on Medical Resource Use and Costs: Results of HF-ACTION. JOURNAL OF CARDIAC FAILURE, 15(6), S93.

Evidence-based perspectives on pay for performance and quality of patient care and outcomes in emergency medicine
Glickman, S. W., Schulman, K. A., Peterson, E. D., Hocker, M. B., & Cairns, C. B. (2008). Evidence-based perspectives on pay for performance and quality of patient care and outcomes in emergency medicine. ANNALS OF EMERGENCY MEDICINE, 51(5), 622–31.

Medical Resource Use, Costs and Quality of Life are Similar Between Patients with Acute Decompensated Heart Failure Treated with Nesiritide Versus Placebo
Reed, S. D., Kaul, P., Hernandez, A. F., Li, Y., Eapen, Z. J., Schulman, K. A., … Califf, R. M. (2011). Medical Resource Use, Costs and Quality of Life are Similar Between Patients with Acute Decompensated Heart Failure Treated with Nesiritide Versus Placebo. CIRCULATION, 124(21).

Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool A User-Friendly Spreadsheet Program to Estimate Costs of Providing Patient-Centered Interventions
Reed, S. D., Li, Y., Kamble, S., Polsky, D., Graham, F. L., Bowers, M. T., … Riegel, B. J. (2012). Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool A User-Friendly Spreadsheet Program to Estimate Costs of Providing Patient-Centered Interventions. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 5(1), 113–19.

End Point Selection in Acute Decompensated Heart Failure Clinical Trials: Economic End Points
Reed, S. D., Eapen, Z. J., & Schulman, K. A. (2011). End Point Selection in Acute Decompensated Heart Failure Clinical Trials: Economic End Points. HEART FAILURE CLINICS, 7(4), 529-+.

Relationship of age and exercise performance in patients with heart failure: The HF-ACTION study
Forman, D. E., Clare, R., Kitzman, D. W., Ellis, S. J., Fleg, J. L., Chiara, T., … Kraus, W. E. (2009). Relationship of age and exercise performance in patients with heart failure: The HF-ACTION study. AMERICAN HEART JOURNAL, 158(4), S6–S15.

Redistribution of Health Care Costs after the Adoption of Positron Emission Tomography among Medicare Beneficiaries with Non-Small-Cell Lung Cancer, 1998-2005
Dinan, M. A., Curtis, L. H., Carpenter, W. R., Biddle, A. K., Abernethy, A. P., Patz, E. F., … Weinberger, M. (2014). Redistribution of Health Care Costs after the Adoption of Positron Emission Tomography among Medicare Beneficiaries with Non-Small-Cell Lung Cancer, 1998-2005. JOURNAL OF THORACIC ONCOLOGY, 9(4), 512–18.

Cost-effectiveness of the 21-gene recurrence score assay in the setting of multifactorial decision making for chemotherapy in early-stage breast cancer
Reed, S. D., Dinan, M. A., Schulman, K. A., & Lyman, G. H. (2012). Cost-effectiveness of the 21-gene recurrence score assay in the setting of multifactorial decision making for chemotherapy in early-stage breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 30(15).

Overbilling and Informed Financial Consent - A Contractual Solution
Richman, B. D., Hall, M. A., & Schulman, K. A. (2012). Overbilling and Informed Financial Consent - A Contractual Solution. NEW ENGLAND JOURNAL OF MEDICINE, 367(5), 396–97.

Drug development risk and the cost of capital
Baras, A. I., Baras, A. S., & Schulman, K. A. (2012). Drug development risk and the cost of capital. NATURE REVIEWS DRUG DISCOVERY, 11(5), 347–48.

THE COST-EFFECTIVENESS OF A TELAPREVIR-INCLUSIVE REGIMEN AS INITIAL THERAPY FOR GENOTYPE 1 HEPATITIS C INFECTION IN INDIVIDUALS WITH THE CC IL-28B POLYMORPHISM
Gellad, Z. F., Naggie, S., Reed, S. D., Clark, P. J., Thompson, A. J., Schulman, K. A., & Muir, A. J. (2011). THE COST-EFFECTIVENESS OF A TELAPREVIR-INCLUSIVE REGIMEN AS INITIAL THERAPY FOR GENOTYPE 1 HEPATITIS C INFECTION IN INDIVIDUALS WITH THE CC IL-28B POLYMORPHISM. HEPATOLOGY, 54, 417A–418A.

Can We Begin With the End in Mind? End-of-Life Care Preferences Before Long-term Dialysis
Patel, U. D., & Schulman, K. A. (2012). Can We Begin With the End in Mind? End-of-Life Care Preferences Before Long-term Dialysis. ARCHIVES OF INTERNAL MEDICINE, 172(8), 663–64.

Relationship Between Patient Satisfaction With Inpatient Care and Hospital Readmission Within 30 Days
Boulding, W., Glickman, S. W., Manary, M. P., Schulman, K. A., & Staelin, R. (2011). Relationship Between Patient Satisfaction With Inpatient Care and Hospital Readmission Within 30 Days. AMERICAN JOURNAL OF MANAGED CARE, 17(1), 41–48.

Decision making and quality of life in the treatment of cancer: a review
Zafar, S. Y., Alexander, S. C., Weinfurt, K. P., Schulman, K. A., & Abernethy, A. P. (2009). Decision making and quality of life in the treatment of cancer: a review. SUPPORTIVE CARE IN CANCER, 17(2), 117–27.

Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial
Massie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Ezekowitz, M., … Warren, S. R. (2009). Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial. CIRCULATION, 119(12), 1616–24.

Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary Stents
Weinfurt, K. P., Seils, D. M., Tzeng, J. P., Lin, L., Schulman, K. A., & Califf, R. M. (2008). Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary Stents. PLOS ONE, 3(5), e2128.

Hemoglobin, Exercise Training, and Health Status in Patients With Chronic Heart Failure (from the HF-ACTION Randomized Controlled Trial)
Pina, I. L., Lin, L., Weinfurt, K. P., Isitt, J. J., Whellan, D. J., Schulman, K. A., & Flynn, K. E. (2013). Hemoglobin, Exercise Training, and Health Status in Patients With Chronic Heart Failure (from the HF-ACTION Randomized Controlled Trial). AMERICAN JOURNAL OF CARDIOLOGY, 112(7), 971–76.

Addressing the systems-based practice requirement with health policy content and educational technology
Nagler, A., Andolsek, K., Dossary, K., Schlueter, J., & Schulman, K. (2010). Addressing the systems-based practice requirement with health policy content and educational technology. MEDICAL TEACHER, 32(12), E559–E565.

Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction A VALIANT Study (Valsartan In Acute Myocardial Infarction)
Lewis, E. F., Li, Y., Pfeffer, M. A., Solomon, S. D., Weinfurt, K. P., Velazquez, E. J., … Reed, S. D. (2014). Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction A VALIANT Study (Valsartan In Acute Myocardial Infarction). JACC-HEART FAILURE, 2(2), 159–65.

Can the Seattle Proportional Risk Model Identify Patients With a Greater ICD Benefit in HF-ACTION?
Levy, W. C., Li, Y., Zile, M., Shadman, R., Dardas, T., Whellan, D., … Reed, S. (2012). Can the Seattle Proportional Risk Model Identify Patients With a Greater ICD Benefit in HF-ACTION? JOURNAL OF CARDIAC FAILURE, 18(8), S50.

Assessment of Left Ventricular Function in Older Medicare Beneficiaries With Newly Diagnosed Heart Failure
Curtis, L. H., Greiner, M. A., Shea, A. M., Whellan, D. J., Hammill, B. G., Schulman, K. A., & Douglas, P. S. (2011). Assessment of Left Ventricular Function in Older Medicare Beneficiaries With Newly Diagnosed Heart Failure. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 4(1), 85–91.

Geographic Variation and Trends in Carotid Imaging Among Medicare Beneficiaries, 2001 to 2006
Curtis, L. H., Greiner, M. A., Patel, M. R., Duncan, P. W., Schulman, K. A., & Matchar, D. B. (2010). Geographic Variation and Trends in Carotid Imaging Among Medicare Beneficiaries, 2001 to 2006. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 3(6), 599–606.

Relationships among the Kansas City cardiomyopathy questionnaire and clinical measures in patients with heart failure
Flynn, K. E., Lin, L., Ellis, S., Fine, L., Pina, I., Roll, S. K., … Weinfurt, K. (2008). Relationships among the Kansas City cardiomyopathy questionnaire and clinical measures in patients with heart failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 51(10), A269.

Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer
Reed, S. D., Dinan, M. A., Schulman, K. A., & Lyman, G. H. (2013). Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer. GENETICS IN MEDICINE, 15(3), 203–11.

Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries
Hammill, B. G., Curtis, L. H., Schulman, K. A., & Whellan, D. J. (2010). Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries. CIRCULATION, 121(1), 63–70.

Cancer Patient Preferences for Quality and Length of Life
Meropol, N. J., Egleston, B. L., Buzaglo, J. S., Benson, A. B., Cegala, D. J., Diefenbach, M. A., … Weinfurt, K. P. (2008). Cancer Patient Preferences for Quality and Length of Life. CANCER, 113(12), 3459–66.

Lessons From India In Organizational Innovation: A Tale Of Two Heart Hospitals
Richman, B. D., Udayakumar, K., Mitchell, W., & Schulman, K. A. (2008). Lessons From India In Organizational Innovation: A Tale Of Two Heart Hospitals. HEALTH AFFAIRS, 27(5), 1260–70.

Expectations of benefit in early-phase clinical trials: Implications for assessing the adequacy of informed consent
Weinfurt, K. P., Seils, D. M., Tzeng, J. P., Compton, K. L., Sulmasy, D. P., Astrow, A. B., … Meropol, N. J. (2008). Expectations of benefit in early-phase clinical trials: Implications for assessing the adequacy of informed consent. MEDICAL DECISION MAKING, 28(4), 575–81.

Resource Use in the Last 6 Months of Life Among Medicare Beneficiaries With Heart Failure, 2000-2007
Unroe, K. T., Greiner, M. A., Hernandez, A. F., Whellan, D. J., Kaul, P., Schulman, K. A., … Curtis, L. H. (2011). Resource Use in the Last 6 Months of Life Among Medicare Beneficiaries With Heart Failure, 2000-2007. ARCHIVES OF INTERNAL MEDICINE, 171(3), 196–203.

Costs of Inpatient Care Among Medicare Beneficiaries With Heart Failure, 2001 to 2004
Whellan, D. J., Greiner, M. A., Schulman, K. A., & Curtis, L. H. (2010). Costs of Inpatient Care Among Medicare Beneficiaries With Heart Failure, 2001 to 2004. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 3(1), 33–40.

The Mis-Measure of Physician Performance
Glickman, S. W., & Schulman, K. A. (2013). The Mis-Measure of Physician Performance. AMERICAN JOURNAL OF MANAGED CARE, 19(10), 782–85.

In-Hospital Resource Use and Medical Costs in the Last Year of Life by Mode of Death (from the HF-ACTION Randomized Controlled Trial)
Reed, S. D., Li, Y., Dunlap, M. E., Kraus, W. E., Samsa, G. P., Schulman, K. A., … Whellan, D. J. (2012). In-Hospital Resource Use and Medical Costs in the Last Year of Life by Mode of Death (from the HF-ACTION Randomized Controlled Trial). AMERICAN JOURNAL OF CARDIOLOGY, 110(8), 1150–55.

Pattern and Predictors of the Initiation of Biologic Agents for the Treatment of Rheumatoid Arthritis in the United States: An Analysis Using a Large Observational Data Bank
DeWitt, E. M., Lin, L., Glick, H. A., Anstrom, K. J., Schulman, K. A., & Reed, S. D. (2009). Pattern and Predictors of the Initiation of Biologic Agents for the Treatment of Rheumatoid Arthritis in the United States: An Analysis Using a Large Observational Data Bank. CLINICAL THERAPEUTICS, 31(8), 1871–80.

Long-term Outcomes and Costs of Ventricular Assist Devices among United States Medicare Beneficiaries
Hernandez, A. F., Shea, A., Milano, C. A., Rogers, J. G., Hammill, B. G., Schulman, K. A., … Curtis, L. H. (2008). Long-term Outcomes and Costs of Ventricular Assist Devices among United States Medicare Beneficiaries. CIRCULATION, 118(18), S1016–S1017.

Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
Eapen, Z. J., Hammill, B. G., Setoguchi, S., Schulman, K. A., Peterson, E. D., Hernandez, A. F., & Curtis, L. H. (2013). Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2(5), e000242.

Animal, Vegetable, or ... Clinical Trial?
Yancy, W. S., Maciejewski, M. L., & Schulman, K. A. (2010). Animal, Vegetable, or ... Clinical Trial? ANNALS OF INTERNAL MEDICINE, 153(5), 337–U93.

Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model.
Young, R., Bekele, T., Gunn, A., Chapman, N., Chowdhary, V., Corrigan, K., … Yamey, G. (2018). Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model. Gates Open Research, 2, 23.

The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians.
Schulman, K. A., & Dabora, M. (2018). The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians. American Heart Journal, 206, 113–22.

Toward an Effective Innovation Agenda.
Schulman, K. A., & Richman, B. D. (2019). Toward an Effective Innovation Agenda. The New England Journal of Medicine.

Evaluating the quality of antihypertensive drugs in Lagos State, Nigeria.
Ndichu, E. T., Ohiri, K., Sekoni, O., Makinde, O., & Schulman, K. (2019). Evaluating the quality of antihypertensive drugs in Lagos State, Nigeria. PloS One, 14(2), e0211567.

The Implications of "Medicare for All" for US Hospitals.
Schulman, K. A., & Milstein, A. (2019). The Implications of "Medicare for All" for US Hospitals. JAMA.

Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
Levy, W. C., Li, Y., Reed, S. D., Zile, M. R., Shadman, R., Dardas, T., … O'Connor, C. M. (2017). Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients? JACC. Clinical Electrophysiology, 3(3), 291–298.

Racial/ethnic variation in perceptions of medical information sources in Durham County, North Carolina.
Williams, J. E., Anstrom, K. J., Friedman, J. Y., & Schulman, K. A. (2008). Racial/ethnic variation in perceptions of medical information sources in Durham County, North Carolina. North Carolina Medical Journal, 68(6), 391–8.

Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003.
Shea, A. M., Reed, S. D., Curtis, L. H., Alexander, M. J., Villani, J. J., & Schulman, K. A. (2007). Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery, 61(6), 1131–7; discussion 1137–8.

A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
Glickman, S. W., Boulding, W., Staelin, R., Mulgund, J., Roe, M. T., Lytle, B. L., … Peterson, E. D. (2007). A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. American Heart Journal, 154(6), 1206–20.

Promoting quality: the health-care organization from a management perspective.
Glickman, S. W., Baggett, K. A., Krubert, C. G., Peterson, E. D., & Schulman, K. A. (2007). Promoting quality: the health-care organization from a management perspective. International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care, 19(6), 341–8.

Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.
Curtis, L. H., Al-Khatib, S. M., Shea, A. M., Hammill, B. G., Hernandez, A. F., & Schulman, K. A. (2007). Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA, 298(13), 1517–24.

Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.
Inrig, J. K., Reed, S. D., Szczech, L. A., Engemann, J. J., Friedman, J. Y., Corey, G. R., … Fowler, V. G. (2006). Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clinical Journal of the American Society of Nephrology : CJASN, 1(3), 518–24.

Pay for performance, quality of care, and outcomes in acute myocardial infarction.
Glickman, S. W., Ou, F.-S. S., DeLong, E. R., Roe, M. T., Lytle, B. L., Mulgund, J., … Peterson, E. D. (2007). Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA, 297(21), 2373–80.

Developing model language for disclosing financial interests to potential clinical research participants.
Weinfurt, K. P., Allsbrook, J. S., Friedman, J. Y., Dinan, M. A., Hall, M. A., Schulman, K. A., & Sugarman, J. (2007). Developing model language for disclosing financial interests to potential clinical research participants. IRB, 29(1), 1–5.

Changing gender prevalence of stone disease.
Scales, C. D., Curtis, L. H., Norris, R. D., Springhart, W. P., Sur, R. L., Schulman, K. A., & Preminger, G. M. (2007). Changing gender prevalence of stone disease. The Journal of Urology, 177(3), 979–82.

Economic return of clinical trials performed under the pediatric exclusivity program.
Li, J. S., Eisenstein, E. L., Grabowski, H. G., Reid, E. D., Mangum, B., Schulman, K. A., … Benjamin, D. K. (2007). Economic return of clinical trials performed under the pediatric exclusivity program. JAMA, 297(5), 480–8.

Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer.
DePuy, V., Anstrom, K. J., Castel, L. D., Schulman, K. A., Weinfurt, K. P., & Saad, F. (2007). Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 15(7), 869–76.

Relationship between body mass index and prostate cancer screening in the United States.
Scales, C. D., Curtis, L. H., Norris, R. D., Schulman, K. A., Dahm, P., & Moul, J. W. (2007). Relationship between body mass index and prostate cancer screening in the United States. The Journal of Urology, 177(2), 493–8.

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
Eisenstein, E. L., Anstrom, K. J., Kong, D. F., Shaw, L. K., Tuttle, R. H., Mark, D. B., … Califf, R. M. (2007). Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA, 297(2), 159–68.

How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
Reed, S. D., Califf, R. M., & Schulman, K. A. (2006). How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation. Health Affairs (Project Hope), 25(5), 1309–17.

Analytic considerations in economic evaluations of multinational cardiovascular clinical trials.
Torti, F. M., Reed, S. D., & Schulman, K. A. (2006). Analytic considerations in economic evaluations of multinational cardiovascular clinical trials. Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 9(5), 281–91.

Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Reed, S. D., McMurray, J. J., Velazquez, E. J., Schulman, K. A., Califf, R. M., Kober, L., … Murin, J. (2006). Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal, 152(3), 500–8.

Prostate specific antigen testing in men older than 75 years in the United States.
Scales, C. D., Curtis, L. H., Norris, R. D., Schulman, K. A., Albala, D. M., & Moul, J. W. (2006). Prostate specific antigen testing in men older than 75 years in the United States. The Journal of Urology, 176(2), 511–4.

Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.
Reed, S. D., Radeva, J. I., Daniel, D. B., Mody, S. H., Forlenza, J. B., McKenzie, R. S., & Schulman, K. A. (2006). Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. PharmacoEconomics, 24(5), 479–94.

Spending on postapproval drug safety.
Ridley, D. B., Kramer, J. M., Tilson, H. H., Grabowski, H. G., & Schulman, K. A. (2006). Spending on postapproval drug safety. Health Affairs (Project Hope), 25(2), 429–36.

Medicine. A portfolio model of drug development for tuberculosis.
Glickman, S. W., Rasiel, E. B., Hamilton, C. D., Kubataev, A., & Schulman, K. A. (2006). Medicine. A portfolio model of drug development for tuberculosis. Science (New York, N.Y.), 311(5765), 1246–7.

Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia.
Sung, J. C., Curtis, L. H., Schulman, K. A., & Albala, D. M. (2006). Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia. The Journal of Urology, 175(3 Pt 1), 1023–7.

Costs for heart failure with normal vs reduced ejection fraction.
Liao, L., Jollis, J. G., Anstrom, K. J., Whellan, D. J., Kitzman, D. W., Aurigemma, G. P., … Gottdiener, J. S. (2006). Costs for heart failure with normal vs reduced ejection fraction. Archives of Internal Medicine, 166(1), 112–18.

Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes.
Chu, V. H., Crosslin, D. R., Friedman, J. Y., Reed, S. D., Cabell, C. H., Griffiths, R. I., … Fowler, V. G. (2005). Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. The American Journal of Medicine, 118(12), 1416.

The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
Kauf, T. L., Velazquez, E. J., Crosslin, D. R., Weaver, W. D., Diaz, R., Granger, C. B., … Schulman, K. A. (2006). The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. American Heart Journal, 151(1), 206–12.

Trends in health care resource use for hepatitis C virus infection in the United States.
Grant, W. C., Jhaveri, R. R., McHutchison, J. G., Schulman, K. A., & Kauf, T. L. (2005). Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology (Baltimore, Md.), 42(6), 1406–13.

Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg, G. S., Konstance, R. P., Allsbrook, J. S., & Schulman, K. A. (2005). Implications of pharmacogenomics for drug development and clinical practice. Archives of Internal Medicine, 165(20), 2331–6.

Can prospect theory explain risk-seeking behavior by terminally ill patients?
Rasiel, E. B., Weinfurt, K. P., & Schulman, K. A. (2005). Can prospect theory explain risk-seeking behavior by terminally ill patients? Medical Decision Making : an International Journal of the Society for Medical Decision Making, 25(6), 609–13.

Perceived racial/ethnic bias in healthcare in Durham County, North Carolina: a comparison of community and national samples.
Friedman, J. Y., Anstrom, K. J., Weinfurt, K. P., McIntosh, M., Bosworth, H. B., Oddone, E. Z., … Schulman, K. A. (2005). Perceived racial/ethnic bias in healthcare in Durham County, North Carolina: a comparison of community and national samples. North Carolina Medical Journal, 66(4), 267–75.

Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarction.
Meine, T. J., Patel, M. R., DePuy, V., Curtis, L. H., Rao, S. V., Gersh, B. J., … Jollis, J. G. (2005). Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarction. Annals of Internal Medicine, 143(7), 481–5.

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Reed, S. D., Radeva, J. I., Weinfurt, K. P., McMurray, J. J., Pfeffer, M. A., Velazquez, E. J., … Schulman, K. A. (2005). Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). American Heart Journal, 150(2), 323–9.

Impact of disease severity and gastrointestinal side effects on the health state preferences of patients with osteoarthritis.
Chang, J., Kauf, T. L., Mahajan, S., Jordan, J. M., Kraus, V. B., Vail, T. P., … Schulman, K. A. (2005). Impact of disease severity and gastrointestinal side effects on the health state preferences of patients with osteoarthritis. Arthritis and Rheumatism, 52(8), 2366–75.

Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.
Engemann, J. J., Friedman, J. Y., Reed, S. D., Griffiths, R. I., Szczech, L. A., Kaye, K. S., … Fowler, V. G. (2005). Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infection Control and Hospital Epidemiology, 26(6), 534–39.

Reducing the costs of phase III cardiovascular clinical trials.
Eisenstein, E. L., Lemons, P. W., Tardiff, B. E., Schulman, K. A., Jolly, M. K., & Califf, R. M. (2005). Reducing the costs of phase III cardiovascular clinical trials. American Heart Journal, 149(3), 482–8.

Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States.
Curtis, L. H., Masselink, L. E., Østbye, T., Hutchison, S., Dans, P. E., Wright, A., … Schulman, K. A. (2005). Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States. Archives of Pediatrics & Adolescent Medicine, 159(4), 362–6.

Perceptions of racial and ethnic differences in access to healthcare.
Seils, D. M., & Schulman, K. A. (2005). Perceptions of racial and ethnic differences in access to healthcare. North Carolina Medical Journal, 65(6), 350–2.

Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma.
Reed, S. D., Radeva, J. I., Glendenning, G. A., Coleman, R. E., & Schulman, K. A. (2005). Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma. American Journal of Clinical Oncology, 28(1), 8–16.

Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials.
Weinfurt, K. P., Depuy, V., Castel, L. D., Sulmasy, D. P., Schulman, K. A., & Meropol, N. J. (2005). Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials. Cancer, 103(1), 140–7.

Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
Reed, S. D., Anstrom, K. J., Ludmer, J. A., Glendenning, G. A., & Schulman, K. A. (2004). Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia. Cancer, 101(11), 2574–83.

Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
Anstrom, K. J., Reed, S. D., Allen, A. S., Glendenning, G. A., & Schulman, K. A. (2004). Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia. Cancer, 101(11), 2584–92.

Parents' reported preference scores for childhood atopic dermatitis disease states.
Friedman, J. Y., Reed, S. D., Weinfurt, K. P., Kahler, K. H., Walter, E. B., & Schulman, K. A. (2004). Parents' reported preference scores for childhood atopic dermatitis disease states. BMC Pediatrics, 4(1), 21.

Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance.
Kansagra, S. M., Curtis, L. H., & Schulman, K. A. (2004). Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance. JAMA, 292(14), 1717–23.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye, T., Curtis, L. H., Masselink, L. E., Hutchison, S., Wright, A., Dans, P. E., … Krishnan, R. R. (2005). Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Pharmacoepidemiology and Drug Safety, 14(6), 407–15.

Differential pricing of pharmaceuticals in the internet age.
Ridley, D. B., & Schulman, K. A. (2004). Differential pricing of pharmaceuticals in the internet age. The Journal of Ambulatory Care Management, 27(3), 210–4.

The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey.
Curtis, L. H., Law, A. W., Anstrom, K. J., & Schulman, K. A. (2004). The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey. Medical Care, 42(5), 439–46.

Differences in care-seeking behavior for acute chest pain in the United States and Japan.
Liao, L., Whellan, D. J., Tabuchi, K., & Schulman, K. A. (2004). Differences in care-seeking behavior for acute chest pain in the United States and Japan. American Heart Journal, 147(4), 630–5.

Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer.
Reed, S. D., Radeva, J. I., Glendenning, G. A., Saad, F., & Schulman, K. A. (2004). Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. The Journal of Urology, 171(4), 1537–42.

The effect of dementia on outcomes and process of care for Medicare beneficiaries admitted with acute myocardial infarction.
Sloan, F. A., Trogdon, J. G., Curtis, L. H., & Schulman, K. A. (2004). The effect of dementia on outcomes and process of care for Medicare beneficiaries admitted with acute myocardial infarction. Journal of the American Geriatrics Society, 52(2), 173–81.

Exploring options for improving healthcare.
Wang, S. S., Mendelson, D. N., Schulman, K. A., & Mark, D. B. (2004). Exploring options for improving healthcare. American Heart Journal, 147(1), 23–30.

Does the ownership of the admitting hospital make a difference? Outcomes and process of care of Medicare beneficiaries admitted with acute myocardial infarction.
Sloan, F. A., Trogdon, J. G., Curtis, L. H., & Schulman, K. A. (2003). Does the ownership of the admitting hospital make a difference? Outcomes and process of care of Medicare beneficiaries admitted with acute myocardial infarction. Medical Care, 41(10), 1193–205.

Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial.
Reed, S. D., Friedman, J. Y., Gnanasakthy, A., & Schulman, K. A. (2003). Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial. International Journal of Technology Assessment in Health Care, 19(2), 396–406.

The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
Weinfurt, K. P., Castel, L. D., Li, Y., Sulmasy, D. P., Balshem, A. M., Benson, A. B., … Meropol, N. J. (2003). The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer, 98(1), 166–75.

Outcomes research in oncology: improving patients' experiences with cancer treatment.
Schulman, K. A., & Seils, D. M. (2003). Outcomes research in oncology: improving patients' experiences with cancer treatment. Clinical Therapeutics, 25(2), 665–70.

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
Curtis, L. H., Østbye, T., Sendersky, V., Hutchison, S., Allen LaPointe, N. M., Al-Khatib, S. M., … Schulman, K. A. (2003). Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. The American Journal of Medicine, 114(2), 135–41.

Understanding attitudes toward clinical research.
Schulman, K. A. (2003). Understanding attitudes toward clinical research. The Journal of Ambulatory Care Management, 26(1), 88–90.

Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care.
Castel, L. D., Timbie, J. W., Sendersky, V., Curtis, L. H., Feather, K. A., & Schulman, K. A. (2003). Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care. BMC Health Services Research, 3(1), 1.

Treatment patterns and costs associated with sessile colorectal polyps.
Onken, J. E., Friedman, J. Y., Subramanian, S., Weinfurt, K. P., Reed, S. D., Malenbaum, J. H., … Schulman, K. A. (2002). Treatment patterns and costs associated with sessile colorectal polyps. The American Journal of Gastroenterology, 97(11), 2896–901.

A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.
Schulman, K. A., Seils, D. M., Timbie, J. W., Sugarman, J., Dame, L. A., Weinfurt, K. P., … Califf, R. M. (2002). A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. The New England Journal of Medicine, 347(17), 1335–41.

Measuring agreement between patient and proxy responses to multidimensional health-related quality-of-life measures in clinical trials. An application of psychometric profile analysis.
Weinfurt, K. P., Trucco, S. M., Willke, R. J., & Schulman, K. A. (2002). Measuring agreement between patient and proxy responses to multidimensional health-related quality-of-life measures in clinical trials. An application of psychometric profile analysis. Journal of Clinical Epidemiology, 55(6), 608–18.

Medical errors: how the US Government is addressing the problem.
Schulman, K. A., & Kim, J. J. (2000). Medical errors: how the US Government is addressing the problem. Current Controlled Trials in Cardiovascular Medicine, 1(1), 35–37.

Study of Hypertensive Prescribing Practices (SHyPP): A National Survey of Primary Care Physicians.
Schulman, K. A., Mehta, S. S., Gersh, B. J., Schneider, E. C., & Wilcox, C. S. (1999). Study of Hypertensive Prescribing Practices (SHyPP): A National Survey of Primary Care Physicians. Journal of Clinical Hypertension (Greenwich, Conn.), 1(2), 106–114.

Workforce Cost Model for Expanding Congenital and Rheumatic Heart Disease Services in Kenya.
Kontchou, N.-A. T., McCrary, A. W., & Schulman, K. A. (2019). Workforce Cost Model for Expanding Congenital and Rheumatic Heart Disease Services in Kenya. World Journal for Pediatric & Congenital Heart Surgery, 10(3), 321–27.

Evaluating the quality of antihypertensive drugs in Lagos State, Nigeria
Ndichu, E. T., Ohiri, K., Sekoni, O., Makinde, O., & Schulman, K. (2019). Evaluating the quality of antihypertensive drugs in Lagos State, Nigeria. PLOS ONE, 14(2).

The Implications of "Medicare for All" for US Hospitals
Schulman, K. A., & Milstein, A. (2019). The Implications of "Medicare for All" for US Hospitals. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 321(17), 1661–62.

Workforce Cost Model for Expanding Congenital and Rheumatic Heart Disease Services in Kenya
Kontchou, N.-A. T., McCrary, A. W., & Schulman, K. A. (2019). Workforce Cost Model for Expanding Congenital and Rheumatic Heart Disease Services in Kenya. WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY, 10(3), 321–27.

Co-Management by Hospitalists: Why it makes clinical and fiscal sense.
Rohatgi, N., Schulman, K., & Ahuja, N. (2019). Co-Management by Hospitalists: Why it makes clinical and fiscal sense. The American Journal of Medicine.

The unintended consequences of the 340B safety-net drug discount program.
Thomas, S., & Schulman, K. (2020). The unintended consequences of the 340B safety-net drug discount program. Health Services Research.

PATIENT TIME AND INDIRECT COSTS ASSOCIATED WITH SENSOR-AUGMENTED INSULIN PUMP THERAPY IN TYPE 1 DIABETES
Kamble, S., Weinfurt, K. P., Perry, B. M., Schulman, K. A., & Reed, S. D. (2011). PATIENT TIME AND INDIRECT COSTS ASSOCIATED WITH SENSOR-AUGMENTED INSULIN PUMP THERAPY IN TYPE 1 DIABETES. VALUE IN HEALTH, 14(3), A84.

Community hospital oversight of clinical investigators' financial relationships.
Hall, M. A., Weinfurt, K. P., Lawlor, J. S., Friedman, J. Y., Schulman, K. A., & Sugarman, J. (2009). Community hospital oversight of clinical investigators' financial relationships. IRB, 31(1), 7–13.

The medicare modernization act and reimbursement for outpatient chemotherapy - Do patients perceive changes in access to care?
Friedman, J. Y., Curtis, L. H., Hammill, B. G., Dhillon, J. K., Weaver, C. H., Biswas, S., … Schulman, K. A. (2007). The medicare modernization act and reimbursement for outpatient chemotherapy - Do patients perceive changes in access to care? CANCER, 110(10), 2304–12.

Costs of the metabolic syndrome in elderly individuals
Curtis, L. H., Hammill, B. G., Bethel, M. A., Anstrom, K. J., Gottdiener, J. S., & Schulman, K. A. (2007). Costs of the metabolic syndrome in elderly individuals. DIABETES CARE, 30(10), 2553–58.

Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants
Friedman, J. Y., Sugarman, J., Dhillon, J. K., DePuy, V., Pierre, C. K., Dinan, M. A., … Weinfurt, K. P. (2007). Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants. CLINICAL TRIALS, 4(3), 272–78.

Entry and Competition in Generic Biologics
Grabowski, H. G., Ridley, D. B., & Schulman, K. A. (2007). Entry and Competition in Generic Biologics. MANAGERIAL AND DECISION ECONOMICS, 28(4-5), 439–51.

Is there a price to pay for short-term savings in the clinical development of new pharmaceutical products?
Reed, S. D., Califf, R. M., & Schulman, K. A. (2007). Is there a price to pay for short-term savings in the clinical development of new pharmaceutical products? DRUG INFORMATION JOURNAL, 41(4), 491–99.

Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001
Kansagra, S. M., Curtis, L. H., Anstrom, K. J., & Schulman, K. A. (2007). Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001. AMERICAN JOURNAL OF CARDIOLOGY, 99(3), 339–43.

Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study
Liao, L., Anstrom, K. J., Gottdiener, J. S., Pappas, P. A., Whellan, D. J., Kitzman, D. W., … Jollis, J. G. (2007). Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. AMERICAN HEART JOURNAL, 153(2), 245–52.

Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives
Whellan, D. J., Reed, S. D., Liao, L., Gould, S. D., O'Connor, C. M., & Schulman, K. A. (2007). Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives. AMERICAN JOURNAL OF CARDIOLOGY, 99(2), 256–60.

Curbing the cardiovascular disease epidemic: Aligning industry, government, payers, and academics
Califf, R. M., Harrington, R. A., Madre, L. K., Peterson, E. D., Roth, D., & Schulman, K. A. (2007). Curbing the cardiovascular disease epidemic: Aligning industry, government, payers, and academics. HEALTH AFFAIRS, 26(1), 62–74.

Comparison of conflict of interest policies and reported practices in academic medical centers in the United States.
Dinan, M. A., Weinfurt, K. P., Friedman, J. Y., Allsbrook, J. S., Gottlieb, J., Schulman, K. A., … Sugarman, J. (2007). Comparison of conflict of interest policies and reported practices in academic medical centers in the United States. Accountability in Research, 13(4), 325–42.

Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer
Weinfurt, K. P., Anstrom, K. J., Castel, L. D., Schulman, K. A., & Saad, F. (2006). Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer. ANNALS OF ONCOLOGY, 17(6), 986–89.

Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States
Curtis, L. H., Stoddard, J., Radeva, J. I., Hutchison, S., Dans, P. E., Wright, A., … Schulman, K. A. (2006). Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States. HEALTH SERVICES RESEARCH, 41(3), 837–55.

Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants.
Weinfurt, K. P., Dinan, M. A., Allsbrook, J. S., Friedman, J. Y., Hall, M. A., Schulman, K. A., & Sugarman, J. (2006). Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Academic Medicine : Journal of the Association of American Medical Colleges, 81(2), 113–8.

Racial differences in health concern.
Voils, C. I., Oddone, E. Z., Weinfurt, K. P., Friedman, J. Y., Bright, C. M., Schulman, K. A., & Bosworth, H. B. (2006). Racial differences in health concern. Journal of the National Medical Association, 98(1), 36–42.

Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia
Reed, S. D., Radeva, J. I., Daniel, D. B., Fastenau, J. M., Williams, D., & Schulman, K. A. (2005). Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia. CURRENT MEDICAL RESEARCH AND OPINION, 21(10), 1527–33.

Perceived discrimination and reported delay of pharmacy prescriptions and medical tests.
Van Houtven, C. H., Voils, C. I., Oddone, E. Z., Weinfurt, K. P., Friedman, J. Y., Schulman, K. A., & Bosworth, H. B. (2005). Perceived discrimination and reported delay of pharmacy prescriptions and medical tests. Journal of General Internal Medicine, 20(7), 578–83.

Variations in coronary procedure utilization depending on body mass index
Yancy, W. S., Olsen, M. K., Curtis, L. H., Schulman, K. A., Cuffe, M. S., & Oddone, E. Z. (2005). Variations in coronary procedure utilization depending on body mass index. ARCHIVES OF INTERNAL MEDICINE, 165(12), 1381–87.

Metaanalysis and review of heart failure disease management randomized controlled clinical trials
Whellan, D. J., Hasselblad, Peterson, E., O'Connor, C. M., & Schulman, K. A. (2005). Metaanalysis and review of heart failure disease management randomized controlled clinical trials. AMERICAN HEART JOURNAL, 149(4), 722–29.

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer
Weinfurt, K. P., Li, Y., Castel, L. D., Saad, F., Timbie, J. W., Glendenning, G. A., & Schulman, K. A. (2005). The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. ANNALS OF ONCOLOGY, 16(4), 579–84.

Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia
Reed, S. D., Friedman, J. Y., Engemann, J. J., Griffiths, R. I., Anstrom, K. J., Kaye, K. S., … Fowler, V. G. (2005). Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 26(2), 175–83.

Who trusts healthcare institutions? Results from a community-based sample.
Voils, C. I., Oddone, E. Z., Weinfurt, K. P., Friedman, J. Y., Schulman, K. A., & Bosworth, H. B. (2005). Who trusts healthcare institutions? Results from a community-based sample. Ethnicity & Disease, 15(1), 97–103.

Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation.
Radeva, J. I., Reed, S. D., Kaló, Z., Kauf, T. L., Cantu, E., Cretin, N., & Schulman, K. A. (2005). Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation. Clinical Transplantation, 19(1), 122–9.

An exploration of relative health stock in advanced cancer patients
Gaskin, D. J., Weinfurt, K. R., Castel, L. D., DePuy, Li, Y., Balshem, A., … Schulman, K. A. (2004). An exploration of relative health stock in advanced cancer patients. MEDICAL DECISION MAKING, 24(6), 614–24.

Inappropriate prescribing for elderly Americans in a large outpatient population
Curtis, L. H., Ostbye, T., Sendersky, Hutchison, S., Dans, P. E., Wright, A., … Schulman, K. A. (2004). Inappropriate prescribing for elderly Americans in a large outpatient population. ARCHIVES OF INTERNAL MEDICINE, 164(15), 1621–25.

State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction
Patel, M. R., Meine, T. J., Radeva, J., Curtis, L., Rao, S. V., Schulman, K. A., & Jollis, J. G. (2004). State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 44(1), 192–98.

Multinational economic evaluation of valsartan in patients with chronic heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
Reed, S. D., Friedman, J. Y., Velazquez, E. J., Gnanasakthy, A., Califf, R. M., & Schulman, K. A. (2004). Multinational economic evaluation of valsartan in patients with chronic heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT). AMERICAN HEART JOURNAL, 148(1), 122–28.

Socioeconomic status and outcome following acute myocardial infarction in elderly patients
Rao, S. V., Schulman, K. A., Curtis, L. H., Gersh, B. J., & Jollis, J. G. (2004). Socioeconomic status and outcome following acute myocardial infarction in elderly patients. ARCHIVES OF INTERNAL MEDICINE, 164(10), 1128–33.

The warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): Rationale, design, and baseline patient characteristics
Massie, B. M., Krol, W. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G., Collins, J. F., … Warren, S. (2004). The warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): Rationale, design, and baseline patient characteristics. JOURNAL OF CARDIAC FAILURE, 10(2), 101–12.

Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions
Weinfurt, K. P., Castel, L. D., Li, Y., Timbie, J. W., Glendenning, G. A., & Schulman, K. A. (2004). Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions. MEDICAL CARE, 42(2), 164–75.

Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutic misconception
Weinfurt, K. P., Sulmasy, D. P., Schulman, K. A., & Meropol, N. J. (2003). Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutic misconception. THEORETICAL MEDICINE AND BIOETHICS, 24(4), 329–44.

Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication
Meropol, N. J., Weinfurt, K. P., Burnett, C. B., Balshem, A., Benson, A. B., Castel, L., … Schulman, K. A. (2003). Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. JOURNAL OF CLINICAL ONCOLOGY, 21(13), 2589–96.

Economic evaluation of breast cancer treatment: Considering the value of patient choice
Polsky, D., Mandelblatt, J. S., Weeks, J. C., Venditti, L., Hwang, Y. T., Glick, H. A., … Schulman, K. A. (2003). Economic evaluation of breast cancer treatment: Considering the value of patient choice. JOURNAL OF CLINICAL ONCOLOGY, 21(6), 1139–46.

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
Schulman, K. A., Stadtmauer, E. A., Reed, S. D., Glick, H. A., Goldstein, L. J., Pines, J. M., … Glick, J. H. (2003). Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. BONE MARROW TRANSPLANTATION, 31(3), 205–10.

Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey
Law, A. W., Reed, S. D., Sundy, J. S., & Schulman, K. A. (2003). Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 111(2), 296–300.

Patient choice of breast cancer treatment - Impact on health state preferences
Polsky, D., Keating, N. L., Weeks, J. C., & Schulman, K. A. (2002). Patient choice of breast cancer treatment - Impact on health state preferences. MEDICAL CARE, 40(11), 1068–79.

The determinants of HMOs' contracting with hospitals for bypass surgery.
Gaskin, D. J., Escarce, J. J., Schulman, K., & Hadley, J. (2002). The determinants of HMOs' contracting with hospitals for bypass surgery. Health Services Research, 37(4), 963–84.

Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy
Weaver, C. H., Buckner, C. D., Curtis, L. H., Bajwa, K., Weinfurt, K. P., Wilson-Relyea, B. J., & Schulman, K. A. (2002). Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy. BONE MARROW TRANSPLANTATION, 29(2), 159–64.

A claims data approach to defining an episode of care.
Schulman, K. A., Yabroff, K. R., Kong, J., Gold, K. F., Rubenstein, L. E., Epstein, A. J., & Glick, H. (1999). A claims data approach to defining an episode of care. Health Services Research, 34(2), 603–21.

A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease
Castel, L. D., Bajwa, K., Markle, J. P., Timbie, J. W., Zacker, C., & Schulman, K. A. (2001). A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease. SUPPORTIVE CARE IN CANCER, 9(7), 545–51.

The role of reperfusion therapy in paced patients with acute myocardial infarction
Rathore, S. S., Gersh, B. J., Weinfurt, K. P., Oetgen, W. J., Schulman, K. A., & Solomon, A. J. (2001). The role of reperfusion therapy in paced patients with acute myocardial infarction. AMERICAN HEART JOURNAL, 142(3), 516–19.

An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation
Polsky, D., Weinfurt, K. P., Kaplan, B., Kim, J., Fastenau, J., & Schulman, K. A. (2001). An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation. NEPHROLOGY DIALYSIS TRANSPLANTATION, 16(5), 1028–33.

Treatment of patients with myocardial infarction who present with a paced rhythm
Rathore, S. S., Weinfurt, K. P., Gersh, B. J., Oetgen, W. J., Schulman, K. A., & Solomon, A. J. (2001). Treatment of patients with myocardial infarction who present with a paced rhythm. ANNALS OF INTERNAL MEDICINE, 134(8), 644–51.

A comparison of scoring weights for the EuroQol derived from patients and the general public.
Polsky, D., Willke, R. J., Scott, K., Schulman, K. A., & Glick, H. A. (2001). A comparison of scoring weights for the EuroQol derived from patients and the general public. Health Economics, 10(1), 27–37.

Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project).
Berger, A. K., Breall, J. A., Gersh, B. J., Johnson, A. E., Oetgen, W. J., Marciniak, T. A., & Schulman, K. A. (2001). Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project). The American Journal of Cardiology, 87(3), 272–7.

Acute myocardial infarction complicated by heart block in the elderly: Prevalence and outcomes
Rathore, S. S., Gersh, B. J., Berger, P. B., Weinfurt, K. P., Oetgen, W. J., Schulman, K. A., & Solomon, A. J. (2001). Acute myocardial infarction complicated by heart block in the elderly: Prevalence and outcomes. AMERICAN HEART JOURNAL, 141(1), 47–54.

Mobilization, collection, and processing of autologous peripheral blood stem cells: Development of a clinical process with associated costs
Meehan, K. R., Areman, E. M., Ericson, S. G., Matias, C., Seifeldin, R., & Schulman, K. (2000). Mobilization, collection, and processing of autologous peripheral blood stem cells: Development of a clinical process with associated costs. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 9(5), 767–71.

The role of the food and drug administration in pharmacoeconomic evaluation during the drug development process
Kim, J., Morris, C. B., & Schulman, K. A. (2000). The role of the food and drug administration in pharmacoeconomic evaluation during the drug development process. DRUG INFORMATION JOURNAL, 34(4), 1207–13.

The development of standard economic datasets for use in the economic evaluation of medicines
Backhouse, M. E., Gnanasakthy, A., Schulman, K. A., Akehurst, R., & Glick, H. (2000). The development of standard economic datasets for use in the economic evaluation of medicines. DRUG INFORMATION JOURNAL, 34(4), 1273–91.

Time to presentation with acute myocardial infarction in the elderly - Associations with race, sex, and socioeconomic characteristics
Sheifer, S. E., Rathore, S. S., Gersh, B. J., Weinfurt, K. P., Oetgen, W. J., Breall, J. A., & Schulman, K. A. (2000). Time to presentation with acute myocardial infarction in the elderly - Associations with race, sex, and socioeconomic characteristics. CIRCULATION, 102(14), 1651–56.

Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly
Rathore, S. S., Berger, A. K., Weinfurt, K. P., Feinleib, M., Oetgen, W. J., Gersh, B. J., & Schulman, K. A. (2000). Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. CIRCULATION, 102(6), 642–48.

Platelet transfusions: utilization and associated costs in a tertiary care hospital.
Meehan, K. R., Matias, C. O., Rathore, S. S., Sandler, S. G., Kallich, J., LaBrecque, J., … Schulman, K. A. (2000). Platelet transfusions: utilization and associated costs in a tertiary care hospital. American Journal of Hematology, 64(4), 251–6.

Mandated coverage for cancer-screening services: whose guidelines do states follow?
Rathore, S. S., McGreevey, J. D., Schulman, K. A., & Atkins, D. (2000). Mandated coverage for cancer-screening services: whose guidelines do states follow? American Journal of Preventive Medicine, 19(2), 71–8.

Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences.
Mandelblatt, J. S., Hadley, J., Kerner, J. F., Schulman, K. A., Gold, K., Dunmore-Griffith, J., … Winn, R. (2000). Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer, 89(3), 561–73.

The association between institutional primary angioplasty procedure volume and outcome in elderly Americans.
Every, N. R., Maynard, C., Schulman, K., & Ritchie, J. L. (2000). The association between institutional primary angioplasty procedure volume and outcome in elderly Americans. The Journal of Invasive Cardiology, 12(6), 303–8.

The effects of patient sex and race on medical students' ratings of quality of life.
Rathore, S. S., Lenert, L. A., Weinfurt, K. P., Tinoco, A., Taleghani, C. K., Harless, W., & Schulman, K. A. (2000). The effects of patient sex and race on medical students' ratings of quality of life. The American Journal of Medicine, 108(7), 561–6.

Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients.
Weinfurt, K. P., Willke, R. J., Glick, H. A., Freimuth, W. W., & Schulman, K. A. (2000). Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Medical Care, 38(4), 404–10.

Acute myocardial infarction complicated by atrial fibrillation in the elderly - Prevalence and outcomes
Rathore, S. S., Berger, A. K., Weinfurt, K. P., Schulman, K. A., Oetgen, W. J., Gersh, B. J., & Solomon, A. J. (2000). Acute myocardial infarction complicated by atrial fibrillation in the elderly - Prevalence and outcomes. CIRCULATION, 101(9), 969–74.

Impact of quality of life on patient expectations regarding phase I clinical trials
Cheng, J. D., Hitt, J., Koczwara, B., Schulman, K. A., Burnett, C. B., Gaskin, D. J., … Meropol, N. J. (2000). Impact of quality of life on patient expectations regarding phase I clinical trials. JOURNAL OF CLINICAL ONCOLOGY, 18(2), 421–28.

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells
Weaver, C. H., Schulman, K. A., Wilson-Relyea, B., Birch, R., West, W., & Buckner, C. D. (2000). Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells. JOURNAL OF CLINICAL ONCOLOGY, 18(1), 43–53.

Lying for patients - Physician deception of third-party payers
Freeman, V. G., Rathore, S. S., Weinfurt, K. P., Schulman, K. A., & Sulmasy, D. P. (1999). Lying for patients - Physician deception of third-party payers. ARCHIVES OF INTERNAL MEDICINE, 159(19), 2263–70.

A comparison of preference assessment instruments used in a clinical trial: Responses to the visual analog scale from the EuroQol EQ-5D and the health utilities index
Glick, H. A., Polsky, D., Willke, R. J., & Schulman, K. A. (1999). A comparison of preference assessment instruments used in a clinical trial: Responses to the visual analog scale from the EuroQol EQ-5D and the health utilities index. MEDICAL DECISION MAKING, 19(3), 265–75.

Determining an episode of care using claims data - Diabetic foot ulcer
Mehta, S. S., Suzuki, S., Glick, H. A., & Schulman, K. A. (1999). Determining an episode of care using claims data - Diabetic foot ulcer. DIABETES CARE, 22(7), 1110–15.

Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP).
Mehta, S. S., Wilcox, C. S., & Schulman, K. A. (1999). Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP). American Journal of Hypertension, 12(4 Pt 1), 333–40.

Towards a composite scoring solution for the Neurobehavioral Functioning Inventory
Weinfurt, K. P., Willke, R., Glick, H. A., & Schulman, K. A. (1999). Towards a composite scoring solution for the Neurobehavioral Functioning Inventory. QUALITY OF LIFE RESEARCH, 8(1-2), 17–24.

Item responsiveness of a rhinitis and asthma symptom score during a pollen season
Wasserfallen, J. B., Gold, K., Schulman, K. A., & Baraniuk, J. N. (1999). Item responsiveness of a rhinitis and asthma symptom score during a pollen season. JOURNAL OF ASTHMA, 36(5), 459–65.

Regulating manufacturer-affiliated communication in the information age
Schulman, K. A., Abernethy, D. R., Rathore, S. S., & Woosley, R. L. (1999). Regulating manufacturer-affiliated communication in the information age. CLINICAL PHARMACOLOGY & THERAPEUTICS, 65(6), 593–97.

Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients
Berger, A. K., Schulman, K. A., Gersh, B. J., Pirzada, S., Breall, J. A., Johnson, A. E., & Every, N. R. (1999). Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 282(4), 341–48.

Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support
Schulman, K. A., Birch, R., Zhen, B., Pania, N., & Weaver, C. H. (1999). Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support. JOURNAL OF CLINICAL ONCOLOGY, 17(4), 1227–33.

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. ACE inhibitors in the management of congestive heart failure: comparative economic data.
Boyko, W. L., Glick, H. A., & Schulman, K. A. (1999). Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. ACE inhibitors in the management of congestive heart failure: comparative economic data. American Heart Journal, 137(5), S115–9.

The timing of do-not-resuscitate orders and hospital costs.
De Jonge, K. E., Sulmasy, D. P., Gold, K. G., Epstein, A., Harper, M. G., Eisenberg, J. M., & Schulman, K. A. (1999). The timing of do-not-resuscitate orders and hospital costs. Journal of General Internal Medicine, 14(3), 190–2.

The effect of race and sex on physicians' recommendations for cardiac catheterization
Schulman, K. A., Berlin, J. A., Harless, W., Kerner, J. F., Sistrunk, S., Gersh, B. J., … Escarce, J. J. (1999). The effect of race and sex on physicians' recommendations for cardiac catheterization. NEW ENGLAND JOURNAL OF MEDICINE, 340(8), 618–26.

Estimating country-specific cost-effectiveness from multinational clinical trials.
Willke, R. J., Glick, H. A., Polsky, D., & Schulman, K. (1998). Estimating country-specific cost-effectiveness from multinational clinical trials. Health Economics, 7(6), 481–93.

Prescription medication use in older Americans: a national report card on prescribing.
Rathore, S. S., Mehta, S. S., Boyko, W. L., & Schulman, K. A. (1998). Prescription medication use in older Americans: a national report card on prescribing. Family Medicine, 30(10), 733–9.

Resource costing for multinational neurologic clinical trials: Methods and results
Schulman, K., Burke, J., Drummond, M., Davies, L., Carlsson, P., Gruger, J., … Glick, H. (1998). Resource costing for multinational neurologic clinical trials: Methods and results. HEALTH ECONOMICS, 7(7), 629–38.

Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: Report of a workshop
Neymark, N., Kiebert, W., Torfs, K., Davies, L., Fayers, P., Hillner, B., … Simpson, K. (1998). Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: Report of a workshop. EUROPEAN JOURNAL OF CANCER, 34(9), 1317–33.

Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma
Schulman, K. A., Dorsainvil, D., Yabroff, K. R., DiCesare, J., Felser, J., Eisenberg, J. M., & Glick, H. A. (1998). Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. BONE MARROW TRANSPLANTATION, 21(6), 607–14.

Physician resource use and willingness to participate in assisted suicide
Sulmasy, D. P., Linas, B. P., Gold, K. F., & Schulman, K. A. (1998). Physician resource use and willingness to participate in assisted suicide. ARCHIVES OF INTERNAL MEDICINE, 158(9), 974–78.

Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage - Economic evaluation of a phase III clinical trial in Europe and Australia
Glick, H., Willke, R., Polsky, D., Llana, T., Alves, W. M., Kassell, N., & Schulman, K. (1998). Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage - Economic evaluation of a phase III clinical trial in Europe and Australia. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 14(1), 145–60.

Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States
Glick, H. A., Polsky, D., Willke, R. J., Alves, W. M., Kassell, N., & Schulman, K. (1998). Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States. STROKE, 29(2), 351–58.

Treatment choices by seriously Ill patients: The health stock risk adjustment model
Gaskin, D. J., Kong, J., Meropol, N. J., Yabroff, K. R., Weaver, C., & Schulman, K. A. (1998). Treatment choices by seriously Ill patients: The health stock risk adjustment model. MEDICAL DECISION MAKING, 18(1), 84–94.

Remote management of haemodialysis patients: design and implementation of a telemedicine network
Tohme, W. G., Winchester, J. F., Collmann, J., Johnson, A. E., Khanafer, N., Meissner, M. C., … Mun, S. K. (1997). Remote management of haemodialysis patients: design and implementation of a telemedicine network. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 6(5-6), 421–28.

Hemodialysis patient management by telemedicine: design and implementation.
Winchester, J. F., Tohme, W. G., Schulman, K. A., Collmann, J., Johnson, A., Meissner, M. C., … Mun, S. K. (1997). Hemodialysis patient management by telemedicine: design and implementation. ASAIO Journal (American Society for Artificial Internal Organs : 1992), 43(5), M763–6.

Resource utilization control processes as indicators of quality in managed care organizations: a proposal.
Roulidis, Z. C., DeChant, H. K., & Schulman, K. A. (1997). Resource utilization control processes as indicators of quality in managed care organizations: a proposal. The American Journal of Medicine, 103(2), 146–51.

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).
Califf, R. M., Adams, K. F., McKenna, W. J., Gheorghiade, M., Uretsky, B. F., McNulty, S. E., … Swedberg, K. (1997). A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). American Heart Journal, 134(1), 44–54.

Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials.
Wasserfallen, J. B., Gold, K., Schulman, K. A., & Baraniuk, J. N. (1997). Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. The Journal of Allergy and Clinical Immunology, 100(1), 16–22.

Access to bone marrow transplantation for leukemia and lymphoma: The role of sociodemographic factors
Mitchell, J. M., Meehan, K. R., Kong, J., & Schulman, K. A. (1997). Access to bone marrow transplantation for leukemia and lymphoma: The role of sociodemographic factors. JOURNAL OF CLINICAL ONCOLOGY, 15(7), 2644–51.

Confidence intervals for cost-effectiveness ratios: A comparison of four methods
Polsky, D., Glick, H. A., Willke, R., & Schulman, K. (1997). Confidence intervals for cost-effectiveness ratios: A comparison of four methods. HEALTH ECONOMICS, 6(3), 243–52.

Quality assessment in contracting for tertiary care services by HMOs: a case study of three markets.
Schulman, K. A., Rubenstein, L. E., Seils, D. M., Harris, M., Hadley, J., & Escarce, J. J. (1997). Quality assessment in contracting for tertiary care services by HMOs: a case study of three markets. The Joint Commission Journal on Quality Improvement, 23(2), 117–27.

A strategy for collecting pharmacoeconomic data during phase II/III clinical trials
Mauskopf, J., Schulman, K., Bell, L., & Glick, H. (1996). A strategy for collecting pharmacoeconomic data during phase II/III clinical trials. PHARMACOECONOMICS, 9(3), 264–77.

Health systems evaluation of telemedicine: a staged approach.
DeChant, H. K., Tohme, W. G., Mun, S. K., Hayes, W. S., & Schulman, K. A. (1996). Health systems evaluation of telemedicine: a staged approach. Telemedicine Journal : the Official Journal of the American Telemedicine Association, 2(4), 303–12.

Results of the economic evaluation of the first study - A multinational prospective economic evaluation
Schulman, K. A., Buxton, M., Glick, H., Sculpher, M., Guzman, G., Kong, J., … Harley, A. (1996). Results of the economic evaluation of the first study - A multinational prospective economic evaluation. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 12(4), 698–713.

Assessment of joint review of radiologic studies by a primary care physician and a radiologist
Knollmann, B. C., Corson, A. P., Twigg, H. L., & Schulman, K. A. (1996). Assessment of joint review of radiologic studies by a primary care physician and a radiologist. JOURNAL OF GENERAL INTERNAL MEDICINE, 11(10), 608–12.

The economic evaluation of the FIRST study: design of a prospective analysis alongside a multinational phase III clinical trial. Flolan International Randomized Survival Trial.
Schulman, K. A., Glick, H., Buxton, M., Sculpher, M., Backhouse, M., Bell, L., & Eisenberg, J. M. (1996). The economic evaluation of the FIRST study: design of a prospective analysis alongside a multinational phase III clinical trial. Flolan International Randomized Survival Trial. Controlled Clinical Trials, 17(4), 304–15.

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., … Lynch, H. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA, 275(24), 1885–92.

An interactive computer system for formulary management using cost-effectiveness analysis.
Lee, J. H., Glick, H. A., Kinosian, B., & Schulman, K. A. (1995). An interactive computer system for formulary management using cost-effectiveness analysis. M.D. Computing : Computers in Medical Practice, 12(1), 59–65.

Economic evaluation of high-dose chemotherapy and bone marrow transplantation for patients with breast cancer of stage II or IIIA with more than 10 positive lymph nodes at surgical excision.
Schulman, K. A., & Glick, H. A. (1995). Economic evaluation of high-dose chemotherapy and bone marrow transplantation for patients with breast cancer of stage II or IIIA with more than 10 positive lymph nodes at surgical excision. Journal of the National Cancer Institute. Monographs, (19), 45–50.

Physician communication in managed care organizations: opinions of primary care physicians.
Roulidis, Z. C., & Schulman, K. A. (1994). Physician communication in managed care organizations: opinions of primary care physicians. The Journal of Family Practice, 39(5), 446–51.

Ethics, economics, and the publication policies of major medical journals.
Schulman, K., Sulmasy, D. P., & Roney, D. (1994). Ethics, economics, and the publication policies of major medical journals. JAMA, 272(2), 154–6.

SCREENING SURGEONS FOR HIV-INFECTION - ASSESSMENT OF A POTENTIAL PUBLIC-HEALTH PROGRAM
SCHULMAN, K. A., MCDONALD, R. C., LYNN, L. A., FRANK, CHRISTAKIS, N. A., & SCHWARTZ, J. S. (1994). SCREENING SURGEONS FOR HIV-INFECTION - ASSESSMENT OF A POTENTIAL PUBLIC-HEALTH PROGRAM. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 15(3), 147–55.

Patient attitudes toward rooming with persons with HIV infection.
Seltzer, E., Schulman, K. A., Brennan, P. J., & Lynn, L. A. (1993). Patient attitudes toward rooming with persons with HIV infection. The Journal of Family Practice, 37(6), 564–8.

ASSESSING PHYSICIANS ESTIMATES OF THE PROBABILITY OF CORONARY-ARTERY DISEASE - THE INFLUENCE OF PATIENT CHARACTERISTICS
SCHULMAN, K. A., ESCARCE, J. J., EISENBERG, J. M., HERSHEY, J. C., YOUNG, M. J., MCCARTHY, D. M., & WILLIAMS, S. V. (1992). ASSESSING PHYSICIANS ESTIMATES OF THE PROBABILITY OF CORONARY-ARTERY DISEASE - THE INFLUENCE OF PATIENT CHARACTERISTICS. MEDICAL DECISION MAKING, 12(2), 109–14.

COST-EFFECTIVENESS OF LOW-DOSE ZIDOVUDINE THERAPY FOR ASYMPTOMATIC PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
SCHULMAN, K. A., LYNN, L. A., GLICK, H. A., & EISENBERG, J. M. (1991). COST-EFFECTIVENESS OF LOW-DOSE ZIDOVUDINE THERAPY FOR ASYMPTOMATIC PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION. ANNALS OF INTERNAL MEDICINE, 114(9), 798–802.

COST-EFFECTIVENESS OF HA-1A MONOCLONAL-ANTIBODY FOR GRAM-NEGATIVE SEPSIS - ECONOMIC-ASSESSMENT OF A NEW THERAPEUTIC AGENT
SCHULMAN, K. A., GLICK, H. A., RUBIN, H., & EISENBERG, J. M. (1991). COST-EFFECTIVENESS OF HA-1A MONOCLONAL-ANTIBODY FOR GRAM-NEGATIVE SEPSIS - ECONOMIC-ASSESSMENT OF A NEW THERAPEUTIC AGENT. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 266(24), 3466–71.

REDUCING HIGH BLOOD CHOLESTEROL LEVEL WITH DRUGS - COST-EFFECTIVENESS OF PHARMACOLOGICAL MANAGEMENT
SCHULMAN, K. A., KINOSIAN, B., JACOBSON, T. A., GLICK, H., WILLIAN, M. K., KOFFER, H., & EISENBERG, J. M. (1990). REDUCING HIGH BLOOD CHOLESTEROL LEVEL WITH DRUGS - COST-EFFECTIVENESS OF PHARMACOLOGICAL MANAGEMENT. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 264(23), 3025–33.

PROJECTING THE IMPACT OF AIDS ON HOSPITALS
GREEN, J., SINGER, M., WINTFELD, N., SCHULMAN, K., & PASSMAN, L. (1987). PROJECTING THE IMPACT OF AIDS ON HOSPITALS. HEALTH AFFAIRS, 6(3), 19–31.

The Supply-Side Effects of Moral Hazard on Drug Prices
Schulman, K. A. (2018). The Supply-Side Effects of Moral Hazard on Drug Prices. Health Management Policy and Innovation. Retrieved from https://hmpi.org/2018/10/14/the-supply-side-effects-of-moral-hazard-on-drug-prices/

Examining Pharmaceutical Benefits in the United States—A Framework
Chan, A., & Schulman, K. A. (2020). Examining Pharmaceutical Benefits in the United States—A Framework. JAMA Health Forum. Retrieved from https://jamanetwork.com/channels/health-forum/fullarticle/2763175

Private and Public Incentives for Hospitals to Improve the Quality and Reduce the Cost of Care
Liu, X., Schulman, K. A., & Scheinker, D. (2019). Private and Public Incentives for Hospitals to Improve the Quality and Reduce the Cost of Care. Health Management Policy and Innovation. Retrieved from https://hmpi.org/2019/11/25/private-and-public-incentives-for-hospitals-to-improve-the-quality-and-reduce-the-cost-of-care/

A Transparent, Mathematical Model to Evaluate Proposals for Healthcare Reform
Knight, G. M., Schulman, K. A., Milstein, A., Rea, S., Malloy, G., Khaliq, U., & Scheinker, D. (2019). A Transparent, Mathematical Model to Evaluate Proposals for Healthcare Reform. Health Management Policy and Innovation. Retrieved from https://hmpi.org/2019/11/25/a-transparent-mathematical-model-to-evaluate-proposals-for-healthcare-reform/?pdf=2131

A Roadmap To Welcoming Health Care Innovation
Mullangi, S., Ibrahim, S. A., Shah, N. H., & Schulman, K. A. (2019). A Roadmap To Welcoming Health Care Innovation. Health Affairs. Retrieved from https://www.healthaffairs.org/do/10.1377/hblog20191119.155490/full

Identifying and Solving the Problem of Poor-Quality Drugs
Ndichu, E., & Schulman, K. A. (2018). Identifying and Solving the Problem of Poor-Quality Drugs. Health Management Policy and Innovation. Retrieved from https://hmpi.org/2019/11/02/identifying-and-solving-the-problem-of-poor-quality-drugs/

Are Air Ambulances Truly Flying Out Of Reach? Surprise-Billing Policy And The Airline Deregulation Act
Chhabra, K., Schulman, K. A., & Richman, B. D. (2019). Are Air Ambulances Truly Flying Out Of Reach? Surprise-Billing Policy And The Airline Deregulation Act. Health Affairs. Retrieved from 10.1377/hblog20191016.235396

Resolving Surprise Medical Bills
Schulman, K. A., Milstein, A., & Richman, B. D. (2019). Resolving Surprise Medical Bills. Health Affairs. Retrieved from 10.1377/hblog20190628.873493

The Doctor-of-the-Future Is In: Patient Responses to Disruptive Health-Care Innovations
Wood, S., & Schulman, K. A. (2019). The Doctor-of-the-Future Is In: Patient Responses to Disruptive Health-Care Innovations. Journal of the Association for Consumer Research, 4(3).

Decomposing the Value of Health Insurance
Ogbechie-Godec, O. A., Wiske, C. P., & Schulman, K. A. (2019). Decomposing the Value of Health Insurance. Health Management Policy and Innovation. Retrieved from https://hmpi.org/2019/04/21/decomposing-the-value-of-health-insurance/

Committing To Transformation: Chief Innovation Officers And The Role Of Organizational Redesign
Jain, S. S., & Schulman, K. A. (2018). Committing To Transformation: Chief Innovation Officers And The Role Of Organizational Redesign. Health Affairs. Retrieved from 10.1377/hblog20180920.793517

Strengthening the Private Health Sector in Africa: The PharmAccess Solution
Moodley, S., Vasudevan, A., & Schulman, K. A. (2017). Strengthening the Private Health Sector in Africa: The PharmAccess Solution. Health Management Policy and Innovation. Retrieved from https://hmpi.org/2017/09/06/strengthening-the-private-health-sector-in-africa-the-pharmaccess-solution/

A Novel Look At Antitrust Analysis In Health Insurance Markets
Richman, B. D., & Schulman, K. A. (2017). A Novel Look At Antitrust Analysis In Health Insurance Markets. Competition Policy International. Retrieved from https://www.competitionpolicyinternational.com/a-novel-look-at-antitrust-analysis-in-health-insurance-markets/

What U.S. Hospitals Can Still Learn from India’s Private Heart Hospitals
Richman, B. D., & Schulman, K. A. (2017). What U.S. Hospitals Can Still Learn from India’s Private Heart Hospitals. NEJM Catalyst; Innovations in Care Delivery. Retrieved from https://catalyst.nejm.org/doi/full/10.1056/CAT.17.0479

Diffusion of Global Innovations in Health Care: How to Make It Happen
Herzlinger, R. E., & Schulman, K. A. (2016). Diffusion of Global Innovations in Health Care: How to Make It Happen. Health Management Policy and Innovation. Retrieved from https://hmpi.org/2016/10/17/diffusion-of-global-innovations-in-health-care-how-to-make-it-happen/

Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition
Richman, B. D., Mitchell, W., Vidal, E., & Schulman, K. A. (2017). Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition. Loyola University Chicago Law Journal. Retrieved from https://scholarship.law.duke.edu/cgi/viewcontent.cgi?article=6441&context=faculty_scholarship

https://hbr.org/2016/12/we-interviewed-health-care-leaders-about-their-industry-and-theyre-worried
Poku, M., & Schulman, K. A. (2016). https://hbr.org/2016/12/we-interviewed-health-care-leaders-about-their-industry-and-theyre-worried. https://hbr.org/2016/12/we-interviewed-health-care-leaders-about-their-industry-and-theyre-worried.

Enhancing the Value of Statewide Hospital Discharge Data: Improving Clinical Content and Race-Ethnicity Data.
Andrews, R. M., & Schulman, K. A. (2015). Enhancing the Value of Statewide Hospital Discharge Data: Improving Clinical Content and Race-Ethnicity Data. Health Services Research, 50 Suppl 1, 1265–72.

Innovation In Health Care Education: A Call To Action
Herzlinger, R., Kumar, V., Schulman, K. A., & Staman, K. (2015). Innovation In Health Care Education: A Call To Action. Health Affairs. Retrieved from 10.1377/hblog20150129.044213

The Partners HealthCare Settlement and the Future of Health Care Organizations
Richman, B. D., & Schulman, K. A. (2014). The Partners HealthCare Settlement and the Future of Health Care Organizations. ECONOMISTS VOICE, 11(1).

Bridging Health Care’s Innovation-Education Gap
Herzlinger, R., Ramaswamy, V. K., & Schulman, K. A. (2014). Bridging Health Care’s Innovation-Education Gap. Harvard Business Review. Retrieved from https://hbr.org/2014/11/bridging-health-cares-innovation-education-gap.

Triggering management for quality improvement.
Scales, C. D., & Schulman, K. A. (2014). Triggering management for quality improvement. Health Services Research, 49(5), 1401–6.

Could Accountable Care Organizations Stifle Physician Learning and Innovation
Huesch, M. D., & Schulman, K. A. (2014). Could Accountable Care Organizations Stifle Physician Learning and Innovation. Health Management Policy and Innovation.

Organizational Innovation in Health Care
Richman, B. D., Mitchell, W., & Schulman, K. A. (2013). Organizational Innovation in Health Care. Health Management Policy and Innovation. Retrieved from https://pdfs.semanticscholar.org/a795/3098d1f210804a9b327dadd478b6391a6b1f.pdf

Creation of the Business School Alliance for Health Management
Schulman, K. A. (2012). Creation of the Business School Alliance for Health Management. Health Management Policy and Innovation. Retrieved from https://hmpi.org/wp-content/uploads/2017/02/HMPI-Schulman-BAHM.pdf

Moving forward with clinical IT on multiple fronts. An interview with Asif Ahmad and Kevin Schulman, M.D., Duke University Health System/Duke University. Interview by Mark Hagland.
Ahmad, A., & Schulman, K. (2010). Moving forward with clinical IT on multiple fronts. An interview with Asif Ahmad and Kevin Schulman, M.D., Duke University Health System/Duke University. Interview by Mark Hagland. Healthcare Informatics : the Business Magazine for Information and Communication Systems, 27(10), 45–7.

Cost of cancer care: Issues and implications
Meropol, N. J., & Schulman, K. A. (2007). Cost of cancer care: Issues and implications. JOURNAL OF CLINICAL ONCOLOGY, 25(2), 180–86.

Perspectives on the cost of cancer care
Meropol, N. J., & Schulman, K. A. (2007). Perspectives on the cost of cancer care. JOURNAL OF CLINICAL ONCOLOGY, 25(2), 169–70.

Commentary: The unknown benefit of complementary and alternative medicine.
Schulman, K. A. (2004). Commentary: The unknown benefit of complementary and alternative medicine. Journal of Alternative and Complementary Medicine (New York, N.Y.), 10(6), 911.

A multinational review of recent trends and reports in dementia caregiver burden
Torti, F. M., Gwyther, L. P., Reed, S. D., Friedman, J. Y., & Schulman, K. A. (2004). A multinational review of recent trends and reports in dementia caregiver burden. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 18(2), 99–109.

Commentary: Garson's "Physicians, coverage, quality, and cost: The intertwined caduceus"
Schulman, K. A. (2004). Commentary: Garson's "Physicians, coverage, quality, and cost: The intertwined caduceus". JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 43(1), 6–7.

Sex differences in the referral process for invasive cardiac procedures.
Seils, D. M., Friedman, J. Y., & Schulman, K. A. (2001). Sex differences in the referral process for invasive cardiac procedures. Journal of the American Medical Women's Association (1972), 56(4), 151–4, 160.

The effect of race on the referral process for invasive cardiac procedures.
Einbinder, L. C., & Schulman, K. A. (2000). The effect of race on the referral process for invasive cardiac procedures. Medical Care Research and Review : MCRR, 57 Suppl 1, 162–80.

Race and sex differences in the management of coronary artery disease.
Sheifer, S. E., Escarce, J. J., & Schulman, K. A. (2000). Race and sex differences in the management of coronary artery disease. American Heart Journal, 139(5), 848–57.

Telemedicine: Future promise for dialysis management
Winchester, J. F., Levine, B., Collmann, J., Schulman, K. A., Turner, J. W., Rathore, S., … Mun, S. K. (1999). Telemedicine: Future promise for dialysis management. SEMINARS IN DIALYSIS, 12, S101–S103.

Racial differences in the use of invasive cardiac procedures: A continuous quality improvement approach.
Sheifer, S. E., & Schulman, K. A. (1999). Racial differences in the use of invasive cardiac procedures: A continuous quality improvement approach. American Heart Journal, 138(3 Pt 1), 396–9.

Clinical economics in clinical trials: the measurement of cost and outcomes in the assessment of clinical services through clinical trials.
Schulman, K. A., Ohishi, A., Park, J., Glick, H. A., & Eisenberg, J. M. (1999). Clinical economics in clinical trials: the measurement of cost and outcomes in the assessment of clinical services through clinical trials. The Keio Journal of Medicine, 48(1), 1–11.

Beyond survival: economic analyses of chemotherapy in advanced, inoperable NSCLC.
Mather, D., Sullivan, S. D., & Parasuraman, T. V. (1998). Beyond survival: economic analyses of chemotherapy in advanced, inoperable NSCLC. Oncology (Williston Park, N.Y.), 12(2), 199–209; discussion 210, 215–6 pass.

Outcomes and costs within a disease management program for advanced congestive heart failure
Schulman, K. A., Mark, D. B., & Califf, R. M. (1998). Outcomes and costs within a disease management program for advanced congestive heart failure. AMERICAN HEART JOURNAL, 135(6), S285–S292.

Evaluating cancer costs in NCI trials.
Schulman, K. A., & Boyko, W. L. (1998). Evaluating cancer costs in NCI trials. Cancer Treatment and Research, 97, 37–52.

Pharmacoeconomics: state of the art in 1997.
Schulman, K. A., & Linas, B. P. (1997). Pharmacoeconomics: state of the art in 1997. Annual Review of Public Health, 18, 529–48.

Mathematical models in decision analysis.
Tom, E., & Schulman, K. A. (1997). Mathematical models in decision analysis. Infection Control and Hospital Epidemiology, 18(1), 65–73.

Economic assessment within the clinical development program
Schulman, K. A., Llana, T., & Yabroff, K. R. (1996). Economic assessment within the clinical development program. MEDICAL CARE, 34(12), DS89–DS95.

The effect of pharmaceutical benefits managers: Is it being evaluated?
Schulman, K. A., Rubenstein, L. E., Abernethy, D. R., Seils, D. M., & Sulmasy, D. P. (1996). The effect of pharmaceutical benefits managers: Is it being evaluated? ANNALS OF INTERNAL MEDICINE, 124(10), 906–13.

Economics of bone marrow transplantation
Schulman, K. A. (1996). Economics of bone marrow transplantation. JOURNAL OF CLINICAL ONCOLOGY, 14(5), 1409–10.

RELATIONSHIPS BETWEEN SPONSORS AND INVESTIGATORS IN PHARMACOECONOMIC AND CLINICAL RESEARCH
SCHULMAN, K. A., RUBENSTEIN, L. E., GLICK, H. A., & EISENBERG, J. M. (1995). RELATIONSHIPS BETWEEN SPONSORS AND INVESTIGATORS IN PHARMACOECONOMIC AND CLINICAL RESEARCH. PHARMACOECONOMICS, 7(3), 206–20.

Evaluation of quality of life for diverse patient populations.
Yabroff, K. R., Linas, B. P., & Schulman, K. (1996). Evaluation of quality of life for diverse patient populations. Breast Cancer Research and Treatment, 40(1), 87–104.

Measuring the cost-effectiveness of cancer care.
Schulman, K. A., & Yabroff, K. R. (1995). Measuring the cost-effectiveness of cancer care. Oncology (Williston Park, N.Y.), 9(6), 523–30, 533; discussion 533–8.

The roles of race and socioeconomic factors in health services research.
Schulman, K. A., Rubenstein, L. E., Chesley, F. D., & Eisenberg, J. M. (1995). The roles of race and socioeconomic factors in health services research. Health Services Research, 30(1 Pt 2), 179–95.

Introduction to clinical economics: assessment of cancer therapies.
Schulman, K. A., Glick, H. A., Yabroff, K. R., & Eisenberg, J. M. (1995). Introduction to clinical economics: assessment of cancer therapies. Journal of the National Cancer Institute. Monographs, (19), 1–9.

The use of evaluation in pharmaceutical reimbursement decisions in the United States.
Schulman, K. A. (1993). The use of evaluation in pharmaceutical reimbursement decisions in the United States. Proceedings: The Canadian Collaborative Workshop on Pharmacoeconomics (pp. 19–23). Excerpta Medica.

Pharmacoeconomics: economic evaluation of pharmaceuticals.
Eisenberg, J. M., Schulman, K. A., Glick, H., & Koffer, H. (1994). Pharmacoeconomics: economic evaluation of pharmaceuticals. Pharmacoepidemiology (pp. 462–493). John Wiley & Sons.

Pharmacoeconomics and clinical practice: a physician's view
Schulman, K. A. (1996). Pharmacoeconomics and clinical practice: a physician's view. Principles of Pharmacoeconomics (pp. 252–270).

Pharmacoeconomics: the economics of pharmaceuticals
Schulman, K. A. (2019). Pharmacoeconomics: the economics of pharmaceuticals . Pharmacoepidemiology. John Wiley & Sons.

The Economics of Precision Medicine
Schulman, K. A. (2016). The Economics of Precision Medicine. Insights and Innovation in Neuromuscular Medicine. AANEM.

Ethics of clinical research: an overview and emerging issues
Wong, Y. W., & Schulman, K. A. (2013). Ethics of clinical research: an overview and emerging issues. Understanding Clinical Research. McGraw-Hill Education.

Pharmacoeconomics: economic evaluation of pharmaceuticals
Schulman, K. A., Glick, H. A., Polsky, D., & Reed, S. D. (2012). Pharmacoeconomics: economic evaluation of pharmaceuticals. Pharmacoepidemiology (pp. 678–708). John Wiley & Sons.

Property, privacy and the pursuit of integrated medical records
Hall, M. A., & Schulman, K. A. (2010). Property, privacy and the pursuit of integrated medical records. The Fragmentation of U.S. Health Care: Causes and Solutions. Oxford University Press.

. Introduction to decision analysis
Schulman, K. A., Glick, H. A., & Detsky, A. S. (1998). . Introduction to decision analysis. Evidence Based Cardiology (pp. 92–111). BMJ Books.

Evaluating cancer costs in NCI trials
Schulman, K. A., & Boyko, W. L. (1998). Evaluating cancer costs in NCI trials. Cancer Policy: Research and Methods. Kluwer Academic Publishers.

Costs and outcomes
Schulman, K. A. (1998). Costs and outcomes. Internal Medicine. Mosby.

Pharmacoeconomics
Gonzales, J., & Schulman, K. A. (1999). Pharmacoeconomics. Maintenance Pharmacotherapies for Neuropsychiatric Disorders (pp. 29–54). Brunner/Mazel.

Pharmacoeconomics: economic evaluation of pharmaceuticals.
Schulman, K. A., Glick, H., Polsky, D., & Eisenberg, J. M. (2000). Pharmacoeconomics: economic evaluation of pharmaceuticals. Pharmacoepidemiology (pp. 573–601). John Wiley & Sons.

Pharmacoeconomics
Schulman, K. A., Glick, H. A., Polsky, D., John, K. R., & Eisenberg, J. M. (2001). Pharmacoeconomics. Drug Benefits and Risks: International Textbook on Clinical Pharmacology (pp. 37–53). John Wiley & Sons.

Trial-based economic evaluations: an overview of design and analysis.
Glick, H. A., Polsky, D. P., & Schulman, K. A. (2001). Trial-based economic evaluations: an overview of design and analysis. . Economic Evaluation in Health Care: Merging Theory With Practice. (pp. 113–140). Oxford University Press.

Clinical economics
Schulman, K. A., & Seils, D. M. (2002). Clinical economics. Interactive Textbook on Clinical Symptom Research [online book]. National Institute of Dental and Craniofacial Research.

Introduction to decision analysis
Schulman, K. A., Glick, H. A., & Detsky, A. S. (2003). Introduction to decision analysis. Evidence Based Cardiology (pp. 56–70). BMJ Books.

Costs of care and cost-effectiveness analysis: primary prevention of coronary artery disease
Kaul, P., & Schulman, K. A. (2003). Costs of care and cost-effectiveness analysis: primary prevention of coronary artery disease. Cardiovascular Health Care Economics (pp. 157–172). The Humana Press.

Pharmacoeconomics: economic evaluation of pharmaceuticals
Schulman, K. A., Glick, H. A., & Polsky, D. (2005). Pharmacoeconomics: economic evaluation of pharmaceuticals. Pharmacoepidemiology (pp. 629–652).

Pharmacoeconomics: economic evaluation of pharmaceuticals
Schulman, K. A., Glick, H. A., & Polsky, D. (2001). Pharmacoeconomics: economic evaluation of pharmaceuticals. Textbook of Pharmacoepidemiology (pp. 333–343). John Wiley & Sons.

Understanding types of innovation and implications for policy
Schulman, K. A. (2008). Understanding types of innovation and implications for policy. Diffusion and Use of Genomic Innovations in Health and Medicine: Workshop Summary. National Academies Press.

Economics and quality of life in the advanced heart failure patient
Whellen, D. J., Yager, J. E. E., Friedman, J. Y., & Schulman, K. A. (2005). Economics and quality of life in the advanced heart failure patient. Managing Acute Decompensated Heart Failure. Taylor & Francis.

RANITIDINE TO PREVENT RECURRENCE OF DUODENAL-ULCER
MERKEL, P. A., & SCHULMAN, K. A. (1989). RANITIDINE TO PREVENT RECURRENCE OF DUODENAL-ULCER. NEW ENGLAND JOURNAL OF MEDICINE, 321(12), 835.

SCREENING FOR COLORECTAL-CANCER
SCHULMAN, K. (1990). SCREENING FOR COLORECTAL-CANCER. ANNALS OF INTERNAL MEDICINE, 113(4), 333.

Gastric obstruction with extended-release tablets.
Hennessy, S., Fogarty, P. M., Schulman, K. A., & Mignott, H. (1991). Gastric obstruction with extended-release tablets. DICP : the Annals of Pharmacotherapy, 25(6), 678–9.

'Medicare for all’ won’t fix soaring healthcare costs
Schulman, K. A. (2019). 'Medicare for all’ won’t fix soaring healthcare costs. Los Angeles Times. Retrieved from https://www.latimes.com/opinion/story/2019-11-15/medicare-for-all-health-care-costs

Stop outrageous air ambulance bills by disclosing the transport price
Schulman, K. A., Richman, B. D., & Milstein, A. (2019). Stop outrageous air ambulance bills by disclosing the transport price. STAT News. Retrieved from https://www.statnews.com/2019/01/08/stop-outrageous-air-ambulance-bills/

Mergers between health insurers and pharmacy benefit managers could be bad for your health
Richman, B. D., & Schulman, K. A. (2018). Mergers between health insurers and pharmacy benefit managers could be bad for your health. STAT News. Retrieved from https://www.statnews.com/2018/06/01/mergers-health-insurers-pharmacy-benefit-managers/

Rapid flurry of new drug pricing leaves no room for public debate
Schulman, K. A. (2017). Rapid flurry of new drug pricing leaves no room for public debate. The Hill. Retrieved from https://thehill.com/opinion/healthcare/357389-rapid-flurry-of-new-drug-pricing-leaves-no-room-for-public-debate

Systemic and Ocular Risks Associated With Therapies for Macular Degeneration: Clarification vs Confusion-Reply.
Curtis, L. H., Hammill, B. G., Schulman, K. A., & Cousins, S. W. (2012). Systemic and Ocular Risks Associated With Therapies for Macular Degeneration: Clarification vs Confusion-Reply. Archives of Ophthalmology (Chicago, Ill. : 1960), 130(6), 806–7.

Searching for industry modernization.
Richman, B. D., Mitchell, W., & Schulman, K. A. (2009). Searching for industry modernization. Modern Healthcare. Retrieved from https://www.modernhealthcare.com/article/20090209/MODERNPHYSICIAN/302019971/searching-for-industry-modernization

Developing drugs for tuberculosis - Response
Glickman, S. W., Rasiel, E. B., Hamilton, C. D., & Schulman, K. A. (2007). Developing drugs for tuberculosis - Response. SCIENCE, 315(5815), 1076–77.

Physician-patient communication in phase I cancer trials - Reply
Meropol, N. J., Castel, L. D., Schulman, K. A., & Weinfurt, K. P. (2004). Physician-patient communication in phase I cancer trials - Reply. JOURNAL OF CLINICAL ONCOLOGY, 22(3), 572–73.

Phase I trials: Physician and patient perceptions - In Reply
Meropol, N. J., Weinfurt, K. P., & Schulman, K. A. (2003). Phase I trials: Physician and patient perceptions - In Reply. JOURNAL OF CLINICAL ONCOLOGY, 21(24), 4659–60.

Primary angioplasty vs thrombolysis in elderly patients - Reply
Berger, A. K., Schulman, K. A., Gersh, B. J., & Every, N. R. (2000). Primary angioplasty vs thrombolysis in elderly patients - Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 283(5), 601–2.

ACI-TIPI clinical trial. Acute cardiac ischemia time-insensitive predictive instrument.
Weinfurt, K. P., Rathore, S. S., & Schulman, K. A. (1999). ACI-TIPI clinical trial. Acute cardiac ischemia time-insensitive predictive instrument. Annals of Internal Medicine, 131(6), 476–7.

Race, sex, and physicians' referrals for cardiac catheterization - Reply
Schulman, K. A., Berlin, J. A., & Escarce, J. J. (1999). Race, sex, and physicians' referrals for cardiac catheterization - Reply. NEW ENGLAND JOURNAL OF MEDICINE, 341(4), 286.

Improving Melanoma Screening: MELA Sciences
Herzlinger, R. E., Schulman, K. A., & Dijols, F. (2014). Improving Melanoma Screening: MELA Sciences. Harvard Business School.

MedCath Corporation (C)
Herzlinger, R. E., Schulman, K. A., & Upke, F. F. (2015). MedCath Corporation (C). Harvard Business School Supplement. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=47986

Alnylam: Building a Biotechnology Powerhouse
Schulman, K. A. (2016). Alnylam: Building a Biotechnology Powerhouse. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/pages/item.aspx?num=50992

Aggressive Growth Plans For Zimmer Spine
Schulman, K. A., & Shaw, M. N. (2016). Aggressive Growth Plans For Zimmer Spine. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=50768

Health Catalyst
Schulman, K. A., & Balu, S. (2016). Health Catalyst. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=50175

Savannah Informatics
Schulman, K. A. (2016). Savannah Informatics. https://www.hbs.edu/faculty/Pages/item.aspx?num=50381.

AbbVie
Schulman, K. A., Little, L., Mullangi, S., & Schleicher, S. (2016). AbbVie. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/pages/item.aspx?num=50084

Product Portfolio Management at Genentech
Schulman, K. A., & Gresh, J. (2016). Product Portfolio Management at Genentech. https://www.hbs.edu/faculty/Pages/item.aspx?num=50912.

Health Systems in the Developing World
Schulman, K., Pate, M., & Carbell, G. (2016). Health Systems in the Developing World. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=50753

Blue D Pharmaceuticals
Schulman, K. A., Rasiel, E., & Balu, S. (2016). Blue D Pharmaceuticals. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/pages/item.aspx?num=50670

Nutrition Science Initiative: Are All Calories Created Equal?
Schulman, K., & Dabora, M. (2016). Nutrition Science Initiative: Are All Calories Created Equal? Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=51464

Kada Orthopedics: A Bone of Contention
Schulman, K. A., & Strickland, M. (2017). Kada Orthopedics: A Bone of Contention. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=51616

Shisong Cardiac Center: Kumbo, Cameroon
Schulman, K. A., & Kontchou, N.-A. (2017). Shisong Cardiac Center: Kumbo, Cameroon. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=52062

PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World
Schulman, K. A., Moodley, S., & Vasudevan, A. (2017). PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=52397

China Hospitals Inc.: The Growth of Private Hospitals in China
Schulman, K. A., Yu, X., & Hwang, A. (2017). China Hospitals Inc.: The Growth of Private Hospitals in China. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=52503

From mHealth Hackathon to Reality: Diabetes Care
Schulman, K. A., & Cheek, C. (2017). From mHealth Hackathon to Reality: Diabetes Care. Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=50109

Obesity Management at Kaiser Permanente: A New Mindset for Healthcare Delivery?
Schulman, K. A., Leya, G., & Beveridge, C. (2017). Obesity Management at Kaiser Permanente: A New Mindset for Healthcare Delivery? Harvard Business School. Retrieved from https://www.hbs.edu/faculty/Pages/item.aspx?num=52685

Apple Health Records
Schulman, K. A., & Rosenmoller, M. (2019). Apple Health Records. IESE Business School .

Amazon Alexa and Patient Engagement
Schulman, K. A., & Wood, S. (2019). Amazon Alexa and Patient Engagement. Stanford Graduate School of Business. Retrieved from https://www.gsb.stanford.edu/faculty-research/case-studies/amazon-alexa-patient-engagement

Covid-19 and Health Care's Digital Revolution.
Keesara, S., Jonas, A., & Schulman, K. (2020). Covid-19 and Health Care's Digital Revolution. The New England Journal of Medicine.

Are U.S. Hospitals Still "Recession-proof"?
Teasdale, B., & Schulman, K. A. (2020). Are U.S. Hospitals Still "Recession-proof"? The New England Journal of Medicine.

Exploring payments in the US pharmaceutical market from 2011 to 2019: Update on pharmacy benefit manager impact.
Weinstein, E. P., & Schulman, K. (2020). Exploring payments in the US pharmaceutical market from 2011 to 2019: Update on pharmacy benefit manager impact. American Heart Journal, 227, 107–10.

Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data.
Leal, J., Reed, S. D., Patel, R., Rivero-Arias, O., Li, Y., Schulman, K. A., … Gray, A. M. (2020). Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data. Diabetes Care.

Challenges In Ensuring The Quality Of Generic Medicines.
Schulman, K. A. (2020). Challenges In Ensuring The Quality Of Generic Medicines. Health Affairs (Project Hope), 39(9), 1643–46.

Exploring payments in the US pharmaceutical market from 2011 to 2019: Update on pharmacy benefit manager impact
Weinstein, E. P., & Schulman, K. (2020). Exploring payments in the US pharmaceutical market from 2011 to 2019: Update on pharmacy benefit manager impact. AMERICAN HEART JOURNAL, 227, 107–10.

A Patient Reported Approach to Identify Medical Errors and Improve Patient Safety in the Emergency Department
Glickman, S. W., Mehrotra, A., Shea, C. M., Mayer, C., Strickler, J., Pabers, S., … Schulman, K. A. (2020). A Patient Reported Approach to Identify Medical Errors and Improve Patient Safety in the Emergency Department. JOURNAL OF PATIENT SAFETY, 16(3), 211–15.

Assessment of Electronic Health Record Use Between US and Non-US Health Systems.
Holmgren, A. J., Downing, N. L., Bates, D. W., Shanafelt, T. D., Milstein, A., Sharp, C. D., … Schulman, K. A. (2020). Assessment of Electronic Health Record Use Between US and Non-US Health Systems. JAMA Internal Medicine.

Ethical issues in using ambient intelligence in health-care settings.
Martinez-Martin, N., Luo, Z., Kaushal, A., Adeli, E., Haque, A., Kelly, S. S., … Milstein, A. (2020). Ethical issues in using ambient intelligence in health-care settings. The Lancet. Digital Health.

Beyond Politics - Promoting Covid-19 Vaccination in the United States.
Wood, S., & Schulman, K. (2021). Beyond Politics - Promoting Covid-19 Vaccination in the United States. The New England Journal of Medicine.

The COVID-19 Pandemic-An Opportune Time to Update Medical Licensing.
Mullangi, S., Agrawal, M., & Schulman, K. (2021). The COVID-19 Pandemic-An Opportune Time to Update Medical Licensing. JAMA Internal Medicine.

Reducing administrative costs in US health care: Assessing single payer and its alternatives.
Scheinker, D., Richman, B. D., Milstein, A., & Schulman, K. A. (2021). Reducing administrative costs in US health care: Assessing single payer and its alternatives. Health Services Research.

Estimating health care delivery system value for each US state and testing key associations.
Dieleman, J. L., Kaldjian, A. S., Sahu, M., Chen, C., Liu, A., Chapin, A., … Milstein, A. (2021). Estimating health care delivery system value for each US state and testing key associations. Health Services Research.

Pharmacoeconomics: The Economics of Pharmaceuticals
Schulman, K. A. (2020). Pharmacoeconomics: The Economics of Pharmaceuticals. PHARMACOEPIDEMIOLOGY, 6TH EDITION, 837–866.

When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
Wood, S., & Schulman, K. (2021). When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest. JAMA.

Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
Schulman, K. A., Greicius, M. D., & Richman, B. (2021). Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval? JAMA.

Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos.
Lu, M., Zhao, Q., Poston, K. L., Sullivan, E. V., Pfefferbaum, A., Shahid, M., … Adeli, E. (2021). Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos. Medical Image Analysis, 73, 102179.

Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
Korley, F. K., Durkalski-Mauldin, V., Yeatts, S. D., Schulman, K., Davenport, R. D., Dumont, L. J., … Callaway, C. W. (2021). Early Convalescent Plasma for High-Risk Outpatients with Covid-19. The New England Journal of Medicine.

The No Surprises Act and Informed Financial Consent.
Richman, B., Hall, M., & Schulman, K. (2021). The No Surprises Act and Informed Financial Consent. The New England Journal of Medicine.

Novel strategies to support global promotion of COVID-19 vaccination.
Wood, S., Pate, M. A., & Schulman, K. (2021). Novel strategies to support global promotion of COVID-19 vaccination. BMJ Global Health, 6(10).

New Medicare Technology Add-On Payment Could Be Used As A Market Support Mechanism To Accelerate Antibiotic Innovation.
Gandhi, N., & Schulman, K. A. (2021). New Medicare Technology Add-On Payment Could Be Used As A Market Support Mechanism To Accelerate Antibiotic Innovation. Health Affairs (Project Hope), 40(12), 1926–1934.

The Dysfunctional Health Benefits Market and Implications for US Employers and Employees.
Scheinker, D., Milstein, A., & Schulman, K. (1800). The Dysfunctional Health Benefits Market and Implications for US Employers and Employees. JAMA.

Exploring Workplace Testing with Real-Time Polymerase Chain Reaction SARS-CoV-2 Testing.
Fuentes, L., Shah, N., Kelly, S., Harnett, G., & Schulman, K. A. (2021). Exploring Workplace Testing with Real-Time Polymerase Chain Reaction SARS-CoV-2 Testing. Journal of the American Board of Family Medicine : JABFM, 35(1), 96–101.

Identifying solutions to meet unmet needs of family caregivers using human-centered design.
Termglinchan, V., Daswani, S., Duangtaweesub, P., Assavapokee, T., Milstein, A., & Schulman, K. (1800). Identifying solutions to meet unmet needs of family caregivers using human-centered design. BMC Geriatrics, 22(1), 94.

HSR Invited Commentary Racial Disparities in Healthcare and Health.
Chandran, M., & Schulman, K. A. (2022). HSR Invited Commentary Racial Disparities in Healthcare and Health. Health Services Research.

Trends and Determinants of Retail Prescription Drug Costs.
Teasdale, B., Nguyen, A., van Meijgaard, J., & Schulman, K. A. (2022). Trends and Determinants of Retail Prescription Drug Costs. Health Services Research.

Building a Learning Health System: Creating an Analytical Workflow for Evidence Generation to Inform Institutional Clinical Care Guidelines.
Dash, D., Gokhale, A., Patel, B. S., Callahan, A., Posada, J., Krishnan, G., … Shah, N. H. (2022). Building a Learning Health System: Creating an Analytical Workflow for Evidence Generation to Inform Institutional Clinical Care Guidelines. Applied Clinical Informatics, 13(1), 315–321.

Association between state-level malpractice environment and clinician electronic health record (EHR) time.
Holmgren, A. J., Rotenstein, L., Downing, N. L., Bates, D. W., & Schulman, K. (2022). Association between state-level malpractice environment and clinician electronic health record (EHR) time. Journal of the American Medical Informatics Association : JAMIA.

Digital Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs.
Lee, P., Abernethy, A., Shaywitz, D., Gundlapalli, A. V., Weinstein, J., Doraiswamy, P. M., … Madhavan, S. (2022). Digital Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs. NAM Perspectives, 2022.

Detailed characterization of hospitalized patients infected with the Omicron variant of SARS-CoV-2.
Ozdalga, E., Ahuja, N., Sehgal, N., Hom, J., Weng, Y., Pinsky, B., … Collins, W. (2022). Detailed characterization of hospitalized patients infected with the Omicron variant of SARS-CoV-2. Journal of Internal Medicine.

Price and Quality in the Generic Pharmaceutical Market.
Teasdale, B., Light, D., & Schulman, K. A. (2022). Price and Quality in the Generic Pharmaceutical Market. Circulation, 145(16), 1185–1187.

The Rise and Potential of Physician Unions.
Bowling, D., Richman, B. D., & Schulman, K. A. (2022). The Rise and Potential of Physician Unions. JAMA.

Billing And Insurance-Related Administrative Costs: A Cross-National Analysis.
Richman, B. D., Kaplan, R. S., Kohli, J., Purcell, D., Shah, M., Bonfrer, I., … Schulman, K. A. (2022). Billing And Insurance-Related Administrative Costs: A Cross-National Analysis. Health Affairs (Project Hope), 41(8), 1098–1106.

The impact of expanded telehealth availability on primary care utilization.
Dixit, R. A., Ratwani, R. M., Bishop, J. A., Schulman, K., Sharp, C., Palakanis, K., & Booker, E. (2022). The impact of expanded telehealth availability on primary care utilization. NPJ Digital Medicine, 5(1), 141.

State-level differences in duties permitted to be performed by medical assistants in the delivery of eye care
Reeves, M.-G., Xue, J., Milstein, A., Tabin, G., Goldberg, J. L., & Schulman, K. (2022). State-level differences in duties permitted to be performed by medical assistants in the delivery of eye care. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Commentary on 'The Impact Of Healthcare Strikes On Patient Mortality: A Systematic Review And Meta-Analysis Of Observational Studies.'
Bowling, D. S., Richman, B. D., & Schulman, K. A. (2022). Commentary on 'The Impact Of Healthcare Strikes On Patient Mortality: A Systematic Review And Meta-Analysis Of Observational Studies.'. Health Services Research.

Examining Pharmaceutical Benefits in the United States-A Framework.
Chan, A., & Schulman, K. (2020). Examining Pharmaceutical Benefits in the United States-A Framework. JAMA Health Forum, 1(3), e200291.

An Intergenerational Evaluation of Medicare.
Kumar, W., & Schulman, K. (2022). An Intergenerational Evaluation of Medicare. The American Journal of Medicine.

A Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway.
Wang, P. J., Lu, Y., Mahaffey, K. W., Lin, A., Morin, D. P., Sears, S. F., … Stafford, R. S. (2022). A Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway. Journal of the American Heart Association, e8009.

Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm.
Schulman, K., & Richman, B. (2022). Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm. AMA Journal of Ethics, 24(11), E1063–1068.

Are Patient Satisfaction Instruments Harming Both Patients and Physicians?
Richman, B. D., & Schulman, K. A. (2022). Are Patient Satisfaction Instruments Harming Both Patients and Physicians? JAMA.

A model to design financially sustainable algorithm-enabled remote patient monitoring for pediatric type 1 diabetes care.
Dupenloup, P., Pei, R. L., Chang, A., Gao, M. Z., Prahalad, P., Johari, R., … Scheinker, D. (2022). A model to design financially sustainable algorithm-enabled remote patient monitoring for pediatric type 1 diabetes care. Frontiers in Endocrinology, 13, 1021982.

Restoring Physician Authority in an Era of Hospital Dominance.
Richman, B. D., & Schulman, K. A. (2022). Restoring Physician Authority in an Era of Hospital Dominance. JAMA, 328(24), 2400–2401.

Medicare Overpayment for Outpatient Medication - A Supreme Court Ruling in Context.
Kumar, W., & Schulman, K. (2023). Medicare Overpayment for Outpatient Medication - A Supreme Court Ruling in Context. The New England Journal of Medicine.

Maintaining Health Care Innovations After the Pandemic.
Herzlinger, R., Richman, B. D., & Schulman, K. A. (2023). Maintaining Health Care Innovations After the Pandemic. JAMA Health Forum, 4(2), e225404.

Employer-Based Health Insurance and Employee Compensation.
Schulman, K., & Narayan, A. (2023). Employer-Based Health Insurance and Employee Compensation. JAMA Health Forum, 4(3), e225486.

Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared DecisionMaking Pathway
Wang, P. J., Lu, Y., Mahaffey, K. W., Lin, A., Morin, D. P., Sears, S. F., … Stafford, R. S. (2022). Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared DecisionMaking Pathway. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS.

Do Patient Satisfaction Instruments Harm Patients and Physicians?-Reply.
Richman, B. D., & Schulman, K. A. (2023). Do Patient Satisfaction Instruments Harm Patients and Physicians?-Reply. JAMA, 329(13), 1122–1123.

Challenges to Forming Physician Unions-Reply.
Richman, B. D., & Schulman, K. A. (2023). Challenges to Forming Physician Unions-Reply. JAMA, 329(17), 1519–1520.

Engaging Medicare Beneficiaries in Coverage Choices.
Richman, B. D., & Schulman, K. A. (2023). Engaging Medicare Beneficiaries in Coverage Choices. JAMA.

A data-driven quality-score system for rating drug products and its implications for the health care industry
Dabestani, A., Grossman, S., Nathan, J. P., Bazil, C. W., Costantino, R. C., Fox, E. R., … Yu, K. (2023). A data-driven quality-score system for rating drug products and its implications for the health care industry. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 63(2), 501–506.

Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas: the RACECAT randomized clinical trial (vol 327, pg 1782, 2022)
Richman, B. D., & Schulman, K. A. (2023). Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas: the RACECAT randomized clinical trial (vol 327, pg 1782, 2022). JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 329(13), 1123.

Effect of low-concentration atropine eyedrops vs placebo onmyopia incidence in children: the LAMP2 randomized clinical trial (vol 329, pg 472, 2023)
Richman, B. D., & Schulman, K. A. (2023). Effect of low-concentration atropine eyedrops vs placebo onmyopia incidence in children: the LAMP2 randomized clinical trial (vol 329, pg 472, 2023). JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 329(13), 1123.

Comparison of History of Present Illness Summaries Generated by a Chatbot and Senior Internal Medicine Residents.
Nayak, A., Alkaitis, M. S., Nayak, K., Nikolov, M., Weinfurt, K. P., & Schulman, K. (2023). Comparison of History of Present Illness Summaries Generated by a Chatbot and Senior Internal Medicine Residents. JAMA Internal Medicine.

Time From Authorization by the US Food and Drug Administration to Medicare Coverage for Novel Technologies.
Sexton, Z. A., Perl, J. R., Saul, H. R., Trotsyuk, A. A., Pietzsch, J. B., Ruggles, S. W., … Makower, J. (2023). Time From Authorization by the US Food and Drug Administration to Medicare Coverage for Novel Technologies. JAMA Health Forum, 4(8), e232260.

Revealed versus potential spatial accessibility of healthcare and changing patterns during the COVID-19 pandemic.
Gligoric, K., Kamath, C., Weiss, D. J., Bavadekar, S., Liu, Y., Shekel, T., … Gabrilovich, E. (2023). Revealed versus potential spatial accessibility of healthcare and changing patterns during the COVID-19 pandemic. Communications Medicine, 3(1), 157.

AI Alone Will Not Reduce the Administrative Burden of Health Care.
Schulman, K. A., Nielsen, P. K., & Patel, K. (2023). AI Alone Will Not Reduce the Administrative Burden of Health Care. JAMA.

Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Nayak, A., Vakili, S., Nayak, K., Nikolov, M., Chiu, M., Sosseinheimer, P., … Schulman, K. (2023). Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Network Open, 6(12), e2340232.

Place of Death Before and During the COVID-19 Pandemic.
Teasdale, B., Narayan, A., Harman, S., & Schulman, K. A. (2024). Place of Death Before and During the COVID-19 Pandemic. JAMA Network Open, 7(1), e2350821.

Assessment of Price Variation in Coronary Artery Bypass Surgery at US Hospitals.
Wei, C., Paranjpe, I., Sharma, P., Milligan, M., Lam, M., Heidenreich, P. A., … Sandhu, A. (2024). Assessment of Price Variation in Coronary Artery Bypass Surgery at US Hospitals. Journal of the American Heart Association, e031982.